- Split View
-
Views
-
Cite
Cite
Y. Sanada, J. Hihara, K. Yoshida, Y. Yamaguchi, Esophageal carcinosarcoma with intramural metastasis, Diseases of the Esophagus, Volume 19, Issue 2, 1 April 2006, Pages 119–131, https://doi.org/10.1111/j.1442-2050.2006.00551.x
- Share Icon Share
Summary
A case of esophageal carcinosarcoma is described herein. A 58-year-old man presented with dysphagia and was admitted to our hospital. Imaging studies revealed a type 3 tumor in the upper intrathoracic esophagus with direct invasion to the left main bronchus. Analysis of a biopsy specimen revealed carcinosarcoma. The patient underwent esophageal bypass and chemoradiotherapy. Eight months after surgery, he died of esophago-bronchial fistula. Autopsy examination revealed liver metastasis, peritoneal dissemination and intramural metastasis. The sarcomatous component was predominant in the intramural and liver metastatic lesions.
Introduction
Carcinosarcoma of the esophagus is a rare malignant neoplasm consisting of both carcinomatous and sarcomatous components. With the accumulation of reported cases of esophageal carcinosarcoma, it has become clear that most of these tumors show polypoid-type morphology. In the case described herein, so-called carcinosarcoma forming a type 3 lesion was observed. Autopsy examination in this case revealed unique metastatic lesions, allowing us to speculate on the histogenesis of esophageal carcinosarcoma.
Case Report
A 58-year-old man was admitted to our hospital with 1-month history of progressive dysphagia and weight loss. Neither his medical nor family history included any relevant disease. He had neither jaundice nor ascites, and no tumor was found during physical examination. Tumor marker levels were all within normal limits: squamous cell carcinoma (SCC) antigen, 2.6 ng/mL, and carcinoembryonic antigen (CEA), 1.7 ng/mL. A barium meal study showed a circular irregularly shaped stenosis, 7.5 cm in length, in the upper intrathoracic esophagus. Endoscopic examination revealed a circular type 3 tumor about 25 cm from the incisors (Fig. 1). Analysis of a biopsy specimen showed the tumor to be an SCC with spindle cell components. Computed tomography showed remarkable extraluminal extension and direct invasion to the left main bronchus. On the basis of imaging study and biopsy findings, esophageal carcinosarcoma, T4 N0 mol/L0 stage III, was considered the most likely diagnosis.
In March 2004, the patient underwent esophageal bypass with a stomach tube and external stoma-formation of the remnant esophagus to the left lateral abdominal region.
One month after surgery, the patient underwent chemotherapy (docetaxel + 5FU) and radiation therapy (66 Gy) for 2 months. The reduction rate of the primary lesion was 45% (Fig. 2a,b). However, in June 2004, abdominal computed tomography showed a hypodense tumor with peripheral enhancement in the lateral segment of the liver, the tumor was 1.5 cm in diameter. Liver metastasis was diagnosed. Thus, the chemoradiation was withdrawn, and conservative care was given. In November 2004, the patient died due to esophago-bronchial fistula from the primary tumor. An autopsy was performed. Macroscopically, the primary tumor appeared as a type 3 mass, 7.5 cm in diameter, invading to the left main bronchus (Fig. 3a). In addition, multiple liver metastases appearing as soft tan tumors were found in both lobes (Fig. 3b). In addition, soft tan masses measuring 1.0 cm in diameter were found throughout the serosa of the digestive tract and Douglas pouch, indicative of peritoneal dissemination. In the esophagus, 11 cm away from the primary tumor, papillary tumors measuring 2.0 mm were observed (Fig. 3c). Histopathologically, the primary tumor comprised undifferentiated SCC and pleomorphic spindle cells with oral or long oval nuclei (Fig. 4a). Immunohistochemically, the squamous cell components stained positively for cytokeratin, and the sarcoma components stained positively for vimentin (Fig. 4b). In addition, transitional features between the two components were observed. On the basis of these findings, esophageal carcinosarcoma was diagnosed. Adjacent lymph nodes did not contain any metastasis. Sarcomatous elements predominated in the soft tan masses in the liver (Fig. 4c) and peritoneum. Sarcomatous elements also predominated in the papillary lesion below the primary tumor. This lesion was considered an intramural metastasis (IM) because the nearby epithelium was lined with normal cells (Fig. 4d).
Discussion
Composite malignant tumors with both carcinomatous and sarcomatous components are known as carcinosarcomas. In Japan, esophageal carcinosarcoma reportedly accounts for 0.5–2.8% of all esophageal tumors.1,2 According to the Japanese Society for Esophageal Disease, carcinosarcoma of the esophagus is classified into three subtypes: so-called carcinosarcoma, pseudosarcoma, and true carcinosarcoma.3 However, a recent report notes that no clinical or behavioral differences exist between subtypes.4 Thus, analysis of the characteristics of esophageal carcinosarcoma as a whole is important. In a search of the PUBMED and IGAKU-CHUO-ZASSHI (in Japanese) databases, we found 57 cases of esophageal carcinosarcoma reported between 1995 and 2004 (Tables 1, 2). Patients with esophageal carcinosarcoma, including ours, comprised 53 men and five women and ranged in age between 47 and 84 years. The tumor was located in the upper-third segment in five cases, middle-third segment in 39 cases, lower-third segment in 11 cases, and abdominal esophagus in three cases. Morphologically, 49 tumors were of the polypoid type. Nine were of the ulcerative or infiltrative type. Tumors ranged in size from 1.5 cm to 18 cm. Fifty-four patients underwent curative resection. Of these 54 patients, 15 underwent additional treatment, including chemotherapy (n = 8), chemoradiotherapy (n = 6), and radiotherapy alone (n = 1). According to the criteria of the Japanese Society for Esophageal Disease, tumor grades were T1 (n = 30), T2 (n = 18), T3 (n = 6) and T4 (n = 2). Lymph node metastasis was present in 25 of the 58 patients. Immunohistochemical studies showed that not only epithelial tumor cells but also sarcomatous cells expressed cytokeratin or EMA in 17 patients, and in all 17 cases, transitional features between SCC and sarcoma components were observed, leading to a diagnosis of so-called type carcinosarcoma. Unfortunately, 11 of the total 58 patients were lost to follow-up. Within 12 months after surgery, eight of 47 patients died of recurrent disease. Recurrence was to the lymph nodes in three patients, to the liver in two patients, to the lung in three patients, to the brain in two patients, and local in five patients, and peritoneal dissemination occurred in two patients (including ours). At 2+ years after surgery, six of the 47 patients were reported to be alive and free from disease. Some investigators reported that esophageal carcinosarcoma had low-grade malignant potential and that its intraluminal growth contributed to early detection of the disease, leading to a comparatively good prognosis.5 However, according to our review, the depth of invasion into the esophageal wall was limited to the mucosal or submucosal layer (T1) in 30 patients, and in 12 of these patients (40%), lymph node metastasis was found, contributing to a poor prognosis. Overall, in the treatment of esophageal carcinosarcoma, it is as important to pay attention to lymph node metastasis, as in cases of SCC.
Source . | Age . | Sex . | Symptom . | Tumor markers . | G- CSF . | Location . | Type . | Size . | T . | N . | M . | IM . | IDG . | Stage . | Therapy . | Type (H) . | Immuno-st . | Rec . | Outcome . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEA . | SCC . | Op . | Chemo . | RT . | Ca . | Sa . | ||||||||||||||||||
Saitou H et al. Nippon Rinsho Geka Gakkai Zasshi 58: 1023–6. | 80 | M | dysphagia | * | * | (–) | Mt | 1 | * | * | * | * | * | (–) | * | evulsion | (–) | (–) | so-called | * | * | * | * | * |
Arima M et al. I to Cho 30: 1437–44. | 47 | M | Anemia | 0.69 | 0.82 | (–) | Mt | 0IIc | 5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | EMA | * | (–) | 54 | Alive |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 50 | M | dysphagia | * | * | (–) | Mt | 1 | 9 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 53 | Dead |
Ohhashi S et al. Gastroenterological endoscopy 37: 1162–7. | 53 | F | dysphagia | * | * | (–) | Lt | I + IIa + IIc | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | * | KL, EMA | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 55 | M | chest pain | * | * | (–) | Mt | 0Ip | 2.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | KL | VIM | (–) | 14 | Alive |
Kanamoto A et al. Arch Pathol Laboratory Medical 124: 1685–7. | 55 | M | dysphagia | * | * | (–) | Lt | 0Ip | 1.5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | pseudo | KL | SMA | (–) | 33 | Alive |
Gomi T et al. Kokuritsu Himeji Byouin Kiyo 7: 13–6. | 61 | M | dysphagia | 3.4 | 0.7 | (–) | Lt | 0Ip | 13 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | authentic | * | VIM | (–) | 12 | Alive |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 58: 586–90. | 63 | M | g.f. | * | * | (+) | Mt | 1 | 3.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | Trans: KL, EMA | (–) | 2 | Alive | |
Suzuki K et al. Tokyo Joshi Ikadaigaku Zasshi 65: 109–13. | 66 | M | dysphagia | 1.3 | * | (–) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | * | * | (–) | 12 | Dead |
Ohkura Y. Byori to Rinsho 20: 489–95. | 68 | M | dysphagia | * | * | (–) | Ut | 0Ip | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)pre | (+)pre | so-called | * | Kl | (–) | 8 | Dead |
Saeki H et al. Shokakigeka 24: 1665–71. | 68 | M | * | * | * | (–) | Mt | 0Ip | * | 1b | 0 | 0 | 0 | (–) | I | * | * | * | authentic | * | * | * | * | * |
Kitazono M et al. Nippon Shokaki Geka Gakkai Zasshi 30: 1922–6. | 68 | M | dysphagia | * | * | (–) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (+) | I | Par | (–) | (–) | so-called | * | VIM | * | * | * |
Morimoto Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 3036–40. | 70 | M | fever | * | * | (–) | Mt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | evulsion | (–) | (–) | so-called | * | VIM, SMA | (–) | 12 | Alive |
Nakanowatari M et al. Akitaken Noson Igakkai Zasshi 49: 58–61. | 71 | M | dysphagia | 6.4 | 15 | (–) | Mt | 0Ip | 5 | 1a | 0 | 0 | 0 | (–) | I | EMR | * | * | so-called | KL | SMA | (–) | 1 | Dead |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1094–7. | 76 | M | dysphagia | 6.3 | 1.1 | (+) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL | VIM | LN | 12 | Dead |
Machida A et al. Showa Igakkai Zasshi 64: 321–5. | 78 | M | dysphagia | * | * | (–) | Mt | 0Ip | 8.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)post | (–) | pseudo | * | VIM | lung | 27 | Alive |
Takabayashi N et al. Gann no Rinsho 50: 315–9. | 79 | M | vomiting | * | * | (–) | Lt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM | (–) | 23 | Alive |
Shibazaki H et al. Nippon Rinsho Geka Gakkai Zasshi 63: 2920–5. | 79 | M | dysphagia | * | * | (+) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL, SMA | VIM | (–) | 10 | Alive |
Kawada S et al. Geka 61: 337–40. | 83 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | KL | KL | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 84 | M | dysphagia | * | * | (–) | Mt | 0Ip | 5.5 | 1b | 0 | 0 | 0 | (–) | I | evulsion | * | * | authentic | KL | SMA | (–) | 24 | Alive |
Minakawa Y et al. Teikyou Igaku Zasshi 25: 441–8. | 50 | M | dysphagia | 3.2 | 0.5 | (–) | Mt | 0Ip | 15 | 1b | 2 | 0 | 0 | (+) | II | Sub | (+)post | (–) | so-called | KL, EMA | KL, VIM | (–) | 46 | Alive |
Daiwan C et al. Okinawa Igakkai Zasshi 35: 95–8. | 50 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 2.7 | 2 | 0 | 0 | 0 | (–) | II | Sub | * | * | so-called | * | KL | * | * | * |
Shibata K et al. Nippon Rinsho Geka Gakkai Zasshi 59: 967–71. | 51 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4.5 | 2 | 0 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | EMA | Local | 24 | Alive |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 53 | M | dysphagia | * | * | (–) | Lt | 0Ip | * | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 2 | Dead |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 55 | M | dysphagia | * | * | (–) | Mt | 1 | 14 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | Local | 9 | Dead |
Andou T et al. Shujutsu 58: 1353–6. | 56 | M | dysphagia | 4.1 | * | (–) | Mt | 0Ip | 14.5 | 2 | 1 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | * | (–) | 6 | Alive |
Ohshiro N et al. Nippon Shokaki Geka Gakkai Zasshi 32: 2350–4. | 56 | M | dysphagia | 5.7 | 0.9 | (+) | Lt | 0Ip | 6 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | (–) | 8 | Alive |
Yoshida K et al. Nippon Rinsho Geka Gakkai Zasshi 57: 2295–9. | 56 | M | chest pain | * | * | (–) | Ut | 0Ip | 8 | 2 | 0 | 0 | 0 | (+) | II | Par | (+)post | (–) | so-called | * | * | Local | 10 | Dead |
Hayashi S et al. Gastroenterological endoscopy 38: 2188–99. | 58 | M | dysphagia | 5.1 | 0.53 | (–) | Mt | 1 | 18 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | SMA | (–) | 12 | Alive |
Matsui K et al. Tottori Igaku Zasshi 23: 275–81. | 59 | M | dysphagia | 0.4 | * | (–) | Mt | 3 | 12 | 2 | 0 | 0 | 0 | (+) | II | Total | (–) | (–) | authentic | EMA, KL | VIM | penitoneal | 15 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 59 | M | dysphagia | * | * | (–) | Lt | 1 | 8 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | EMA, VIM | (–) | 6 | Alive |
Asai H et al. Nippon Shokaki Geka Gakkai Zasshi 36: 464–9. | 60 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 2 | 0 | 0 | (–) | II | Sub | (+)pre | (–) | so-called | KL | SMA | (–) | 12 | Alive |
Ohtaka M et al. Pathology Int 52: 657–63. | 61 | M | dysphagia | * | * | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | * | * | * |
Shimura T et al. Nipon Shokaki Naishikyou Gakkai Zassi 46: 253–8. | 62 | M | dysphagia | 0.7 | 0.7 | (–) | Lt | 1 | 8.5 | 2 | 1 | 0 | 0 | (–) | II | Par | * | * | so-called | * | * | * | * | * |
Isogai K et al. Shokaki Naishikyou 13: 243–5. | 64 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 5.5 | 1b | 2 | 0 | 1 | (–) | II | Sub | * | * | so-called | KL | VIM | (–) | 12 | Alive |
Ohtsuka Y et al. Progress of Digestive Endoscopy 54: 102–3. | 67 | M | none | 9.2 | 3.1 | (–) | Mt | 0Ip | 3.5 | 2 | 0 | 0 | 0 | (–) | II | sub | (+)pre | (–) | pseudo | EMA | VIM | * | * | * |
Shimooki O et al. Nippon Kyoubu Geka Gakkai Zasshi 43: 1942–7. | 67 | M | g.f. | * | * | (–) | Mt | 0Ip | 10.5 | 1 | 1 | 0 | 0 | (+) | II | Total | (+)post | (–) | so-called | * | EMA | (–) | 18 | Alive |
Miyake M et al. Gann no Rinsho 49: 127–31. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 6 | 3 | 0 | 0 | 0 | (–) | II | (–) | (+) | (+) | so-called | * | * | (–) | 3 | Alive |
Harada Y. Rinsho Shokaki Naika 15: 585–9. | 68 | M | none | * | * | (–) | Mt | 0Ip | 3 | 1a | 1 | 0 | 0 | (–) | II | Sub | (+)post | (+)post | so-called | * | KL, VIM | (–) | * | * |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 10.5 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 5 | Alive |
Sawamura T et al. Geka 56: 1112–4. | 71 | F | dysphagia | * | 0.9 | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 48 | Alive |
Takemura M et al. Shokakigeka 24: 363–7. | 79 | M | chest pain | 2 | 0.9 | (–) | Mt | 0Ip | 2 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, VIM | Brain | 11 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 79 | M | chest pain | * | * | (–) | Mt | 0Ip | 3 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, Vim | Brain | 17 | Dead |
Moriyama Y et al. Nippon Geka Rengoukei Gakkaishi 24: 216–21. | 54 | M | dysphagia | * | * | (–) | Lt | 3 | 7 | 3 | 2 | 0 | 0 | (–) | III | Total | * | (+)post | so-called | KL | VIM | (+) | 30 | Dead |
Miyazaki K et al. Rinsho to Kenkyuu 78: 713–6. | 57 | M | dysphagia | 1.5 | * | (–) | Mt | 0Ip | 7 | 3 | 1 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 7 | Alive |
Kagawa N et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1098–102. | 60 | M | dysphagia | * | * | (–) | Mt | 1 | 13 | 2 | 2 | 0 | 0 | (+) | III | Sub | (+)pre | (+)pre | so-called | * | AE1,3 | LN | 6 | Dead |
Tkatani Y et al. Nippon Rinsho Geka Gakkai Zasshi 63: 1683–7. | 62 | F | dysphagia | 0.5 | 3.3 | (–) | Mt | 0Ip | 6 | 2 | 3 | 0 | 0 | (+) | III | Sub | (+)post | (–) | so-called | KL, VIM | SMA | H, LM | 37 | Dead |
Akutsu Y et al. Gann no Rinsho 44: 96–101. | 62 | M | dysphagia | * | * | (+) | Mt | 1 | 7 | 3 | 0 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | KL | * | Local | 11 | Dead |
Horimoto M et al. Gastroenterological Endoscopy 41: 2051–7. | 65 | M | dysphagia | 1.9 | 0.5 | (–) | Mt | 0Ip | 8 | 2 | 2 | 0 | 0 | (–) | III | Sub | * | * | so-called | KL | VIM | (–) | 10 | Alive |
Hosodani Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 122–6. | 71 | M | dysphagia | * | 1.8 | (–) | Ut | 1 | 8 | 2 | 3 | 0 | 0 | (–) | III | Sub | (–) | (+)post | so-called | EMA, KL | EMA, VIM | (–) | 9 | Alive |
Iyama H et al. Endoscopic Forum for Digestive Disease 14: 12–7. | 77 | M | dysphagia | 3.9 | 6.1 | (–) | Lt | 0Ip | 5 | 2 | 2 | 0 | 1 | (–) | III | Sub | * | * | so-called | * | KL | * | * | * |
Ohmi R et al. Nippon Rinsho Geka Gakkai Zasshi 60: 97–101. | 59 | M | chest pain | 3.1 | 6.5 | (–) | Mt | 1 | 11 | 2 | 4 | 0 | 0 | (–) | IV a | Sub | (–) | (–) | authentic | KL, EMA | SMA | (–) | 26 | Alive |
Kubota S et al. Surg Today 29: 777–81. | 60 | M | dysphagia | * | * | (–) | Mt | 3 | 10 | 4 | 2 | 0 | 0 | (–) | IV a | Sub | (+)post | (–) | pseudo | KL | VIM | (–) | 10 | Alive |
Sonoda N et al. Gastroenterological endoscopy 41: 42–8. | 63 | M | dysphagia | 1.8 | 0.8 | (–) | Ae | 2 | 4.5 | 3 | 3 | 0 | 0 | (–) | IV a | Par | * | * | authentic | KL | VIM | * | * | * |
Kohara Y et al. Gann no Rinsho 40: 977–82. | 65 | M | dysphagia | 5.7 | 1.2 | (–) | Ut | 0Ip | 3.5 | 1b | 4 | 0 | 0 | (–) | IV a | Total | (+)post | (+)post | so-called | KL | VIM | Skin, Local | 12 | Dead |
Kishimoto H et al. Geka 64: 713–6. | 67 | M | dysphagia | 0.9 | 2.8 | (–) | Lt | 3 | 10 | 3 | 4 | 0 | 1 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | VIM, EMA | LN | 4 | Dead |
Satou Y et al. Akitaken Noson Igakkai Zasshi 39: 11–6. | 66 | M | fever | * | * | (–) | Mt | 0Ip | 14 | 1b | 3 | 0 | 0 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | * | lung | 27 | Dead |
Source . | Age . | Sex . | Symptom . | Tumor markers . | G- CSF . | Location . | Type . | Size . | T . | N . | M . | IM . | IDG . | Stage . | Therapy . | Type (H) . | Immuno-st . | Rec . | Outcome . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEA . | SCC . | Op . | Chemo . | RT . | Ca . | Sa . | ||||||||||||||||||
Saitou H et al. Nippon Rinsho Geka Gakkai Zasshi 58: 1023–6. | 80 | M | dysphagia | * | * | (–) | Mt | 1 | * | * | * | * | * | (–) | * | evulsion | (–) | (–) | so-called | * | * | * | * | * |
Arima M et al. I to Cho 30: 1437–44. | 47 | M | Anemia | 0.69 | 0.82 | (–) | Mt | 0IIc | 5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | EMA | * | (–) | 54 | Alive |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 50 | M | dysphagia | * | * | (–) | Mt | 1 | 9 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 53 | Dead |
Ohhashi S et al. Gastroenterological endoscopy 37: 1162–7. | 53 | F | dysphagia | * | * | (–) | Lt | I + IIa + IIc | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | * | KL, EMA | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 55 | M | chest pain | * | * | (–) | Mt | 0Ip | 2.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | KL | VIM | (–) | 14 | Alive |
Kanamoto A et al. Arch Pathol Laboratory Medical 124: 1685–7. | 55 | M | dysphagia | * | * | (–) | Lt | 0Ip | 1.5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | pseudo | KL | SMA | (–) | 33 | Alive |
Gomi T et al. Kokuritsu Himeji Byouin Kiyo 7: 13–6. | 61 | M | dysphagia | 3.4 | 0.7 | (–) | Lt | 0Ip | 13 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | authentic | * | VIM | (–) | 12 | Alive |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 58: 586–90. | 63 | M | g.f. | * | * | (+) | Mt | 1 | 3.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | Trans: KL, EMA | (–) | 2 | Alive | |
Suzuki K et al. Tokyo Joshi Ikadaigaku Zasshi 65: 109–13. | 66 | M | dysphagia | 1.3 | * | (–) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | * | * | (–) | 12 | Dead |
Ohkura Y. Byori to Rinsho 20: 489–95. | 68 | M | dysphagia | * | * | (–) | Ut | 0Ip | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)pre | (+)pre | so-called | * | Kl | (–) | 8 | Dead |
Saeki H et al. Shokakigeka 24: 1665–71. | 68 | M | * | * | * | (–) | Mt | 0Ip | * | 1b | 0 | 0 | 0 | (–) | I | * | * | * | authentic | * | * | * | * | * |
Kitazono M et al. Nippon Shokaki Geka Gakkai Zasshi 30: 1922–6. | 68 | M | dysphagia | * | * | (–) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (+) | I | Par | (–) | (–) | so-called | * | VIM | * | * | * |
Morimoto Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 3036–40. | 70 | M | fever | * | * | (–) | Mt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | evulsion | (–) | (–) | so-called | * | VIM, SMA | (–) | 12 | Alive |
Nakanowatari M et al. Akitaken Noson Igakkai Zasshi 49: 58–61. | 71 | M | dysphagia | 6.4 | 15 | (–) | Mt | 0Ip | 5 | 1a | 0 | 0 | 0 | (–) | I | EMR | * | * | so-called | KL | SMA | (–) | 1 | Dead |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1094–7. | 76 | M | dysphagia | 6.3 | 1.1 | (+) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL | VIM | LN | 12 | Dead |
Machida A et al. Showa Igakkai Zasshi 64: 321–5. | 78 | M | dysphagia | * | * | (–) | Mt | 0Ip | 8.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)post | (–) | pseudo | * | VIM | lung | 27 | Alive |
Takabayashi N et al. Gann no Rinsho 50: 315–9. | 79 | M | vomiting | * | * | (–) | Lt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM | (–) | 23 | Alive |
Shibazaki H et al. Nippon Rinsho Geka Gakkai Zasshi 63: 2920–5. | 79 | M | dysphagia | * | * | (+) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL, SMA | VIM | (–) | 10 | Alive |
Kawada S et al. Geka 61: 337–40. | 83 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | KL | KL | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 84 | M | dysphagia | * | * | (–) | Mt | 0Ip | 5.5 | 1b | 0 | 0 | 0 | (–) | I | evulsion | * | * | authentic | KL | SMA | (–) | 24 | Alive |
Minakawa Y et al. Teikyou Igaku Zasshi 25: 441–8. | 50 | M | dysphagia | 3.2 | 0.5 | (–) | Mt | 0Ip | 15 | 1b | 2 | 0 | 0 | (+) | II | Sub | (+)post | (–) | so-called | KL, EMA | KL, VIM | (–) | 46 | Alive |
Daiwan C et al. Okinawa Igakkai Zasshi 35: 95–8. | 50 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 2.7 | 2 | 0 | 0 | 0 | (–) | II | Sub | * | * | so-called | * | KL | * | * | * |
Shibata K et al. Nippon Rinsho Geka Gakkai Zasshi 59: 967–71. | 51 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4.5 | 2 | 0 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | EMA | Local | 24 | Alive |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 53 | M | dysphagia | * | * | (–) | Lt | 0Ip | * | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 2 | Dead |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 55 | M | dysphagia | * | * | (–) | Mt | 1 | 14 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | Local | 9 | Dead |
Andou T et al. Shujutsu 58: 1353–6. | 56 | M | dysphagia | 4.1 | * | (–) | Mt | 0Ip | 14.5 | 2 | 1 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | * | (–) | 6 | Alive |
Ohshiro N et al. Nippon Shokaki Geka Gakkai Zasshi 32: 2350–4. | 56 | M | dysphagia | 5.7 | 0.9 | (+) | Lt | 0Ip | 6 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | (–) | 8 | Alive |
Yoshida K et al. Nippon Rinsho Geka Gakkai Zasshi 57: 2295–9. | 56 | M | chest pain | * | * | (–) | Ut | 0Ip | 8 | 2 | 0 | 0 | 0 | (+) | II | Par | (+)post | (–) | so-called | * | * | Local | 10 | Dead |
Hayashi S et al. Gastroenterological endoscopy 38: 2188–99. | 58 | M | dysphagia | 5.1 | 0.53 | (–) | Mt | 1 | 18 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | SMA | (–) | 12 | Alive |
Matsui K et al. Tottori Igaku Zasshi 23: 275–81. | 59 | M | dysphagia | 0.4 | * | (–) | Mt | 3 | 12 | 2 | 0 | 0 | 0 | (+) | II | Total | (–) | (–) | authentic | EMA, KL | VIM | penitoneal | 15 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 59 | M | dysphagia | * | * | (–) | Lt | 1 | 8 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | EMA, VIM | (–) | 6 | Alive |
Asai H et al. Nippon Shokaki Geka Gakkai Zasshi 36: 464–9. | 60 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 2 | 0 | 0 | (–) | II | Sub | (+)pre | (–) | so-called | KL | SMA | (–) | 12 | Alive |
Ohtaka M et al. Pathology Int 52: 657–63. | 61 | M | dysphagia | * | * | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | * | * | * |
Shimura T et al. Nipon Shokaki Naishikyou Gakkai Zassi 46: 253–8. | 62 | M | dysphagia | 0.7 | 0.7 | (–) | Lt | 1 | 8.5 | 2 | 1 | 0 | 0 | (–) | II | Par | * | * | so-called | * | * | * | * | * |
Isogai K et al. Shokaki Naishikyou 13: 243–5. | 64 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 5.5 | 1b | 2 | 0 | 1 | (–) | II | Sub | * | * | so-called | KL | VIM | (–) | 12 | Alive |
Ohtsuka Y et al. Progress of Digestive Endoscopy 54: 102–3. | 67 | M | none | 9.2 | 3.1 | (–) | Mt | 0Ip | 3.5 | 2 | 0 | 0 | 0 | (–) | II | sub | (+)pre | (–) | pseudo | EMA | VIM | * | * | * |
Shimooki O et al. Nippon Kyoubu Geka Gakkai Zasshi 43: 1942–7. | 67 | M | g.f. | * | * | (–) | Mt | 0Ip | 10.5 | 1 | 1 | 0 | 0 | (+) | II | Total | (+)post | (–) | so-called | * | EMA | (–) | 18 | Alive |
Miyake M et al. Gann no Rinsho 49: 127–31. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 6 | 3 | 0 | 0 | 0 | (–) | II | (–) | (+) | (+) | so-called | * | * | (–) | 3 | Alive |
Harada Y. Rinsho Shokaki Naika 15: 585–9. | 68 | M | none | * | * | (–) | Mt | 0Ip | 3 | 1a | 1 | 0 | 0 | (–) | II | Sub | (+)post | (+)post | so-called | * | KL, VIM | (–) | * | * |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 10.5 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 5 | Alive |
Sawamura T et al. Geka 56: 1112–4. | 71 | F | dysphagia | * | 0.9 | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 48 | Alive |
Takemura M et al. Shokakigeka 24: 363–7. | 79 | M | chest pain | 2 | 0.9 | (–) | Mt | 0Ip | 2 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, VIM | Brain | 11 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 79 | M | chest pain | * | * | (–) | Mt | 0Ip | 3 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, Vim | Brain | 17 | Dead |
Moriyama Y et al. Nippon Geka Rengoukei Gakkaishi 24: 216–21. | 54 | M | dysphagia | * | * | (–) | Lt | 3 | 7 | 3 | 2 | 0 | 0 | (–) | III | Total | * | (+)post | so-called | KL | VIM | (+) | 30 | Dead |
Miyazaki K et al. Rinsho to Kenkyuu 78: 713–6. | 57 | M | dysphagia | 1.5 | * | (–) | Mt | 0Ip | 7 | 3 | 1 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 7 | Alive |
Kagawa N et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1098–102. | 60 | M | dysphagia | * | * | (–) | Mt | 1 | 13 | 2 | 2 | 0 | 0 | (+) | III | Sub | (+)pre | (+)pre | so-called | * | AE1,3 | LN | 6 | Dead |
Tkatani Y et al. Nippon Rinsho Geka Gakkai Zasshi 63: 1683–7. | 62 | F | dysphagia | 0.5 | 3.3 | (–) | Mt | 0Ip | 6 | 2 | 3 | 0 | 0 | (+) | III | Sub | (+)post | (–) | so-called | KL, VIM | SMA | H, LM | 37 | Dead |
Akutsu Y et al. Gann no Rinsho 44: 96–101. | 62 | M | dysphagia | * | * | (+) | Mt | 1 | 7 | 3 | 0 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | KL | * | Local | 11 | Dead |
Horimoto M et al. Gastroenterological Endoscopy 41: 2051–7. | 65 | M | dysphagia | 1.9 | 0.5 | (–) | Mt | 0Ip | 8 | 2 | 2 | 0 | 0 | (–) | III | Sub | * | * | so-called | KL | VIM | (–) | 10 | Alive |
Hosodani Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 122–6. | 71 | M | dysphagia | * | 1.8 | (–) | Ut | 1 | 8 | 2 | 3 | 0 | 0 | (–) | III | Sub | (–) | (+)post | so-called | EMA, KL | EMA, VIM | (–) | 9 | Alive |
Iyama H et al. Endoscopic Forum for Digestive Disease 14: 12–7. | 77 | M | dysphagia | 3.9 | 6.1 | (–) | Lt | 0Ip | 5 | 2 | 2 | 0 | 1 | (–) | III | Sub | * | * | so-called | * | KL | * | * | * |
Ohmi R et al. Nippon Rinsho Geka Gakkai Zasshi 60: 97–101. | 59 | M | chest pain | 3.1 | 6.5 | (–) | Mt | 1 | 11 | 2 | 4 | 0 | 0 | (–) | IV a | Sub | (–) | (–) | authentic | KL, EMA | SMA | (–) | 26 | Alive |
Kubota S et al. Surg Today 29: 777–81. | 60 | M | dysphagia | * | * | (–) | Mt | 3 | 10 | 4 | 2 | 0 | 0 | (–) | IV a | Sub | (+)post | (–) | pseudo | KL | VIM | (–) | 10 | Alive |
Sonoda N et al. Gastroenterological endoscopy 41: 42–8. | 63 | M | dysphagia | 1.8 | 0.8 | (–) | Ae | 2 | 4.5 | 3 | 3 | 0 | 0 | (–) | IV a | Par | * | * | authentic | KL | VIM | * | * | * |
Kohara Y et al. Gann no Rinsho 40: 977–82. | 65 | M | dysphagia | 5.7 | 1.2 | (–) | Ut | 0Ip | 3.5 | 1b | 4 | 0 | 0 | (–) | IV a | Total | (+)post | (+)post | so-called | KL | VIM | Skin, Local | 12 | Dead |
Kishimoto H et al. Geka 64: 713–6. | 67 | M | dysphagia | 0.9 | 2.8 | (–) | Lt | 3 | 10 | 3 | 4 | 0 | 1 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | VIM, EMA | LN | 4 | Dead |
Satou Y et al. Akitaken Noson Igakkai Zasshi 39: 11–6. | 66 | M | fever | * | * | (–) | Mt | 0Ip | 14 | 1b | 3 | 0 | 0 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | * | lung | 27 | Dead |
Sex: M: male; F: female; Symptom: g.f.: general fatigue; CEA: carcinoembryonic antigen; SCC: squamous cell carcinoma associated antigen; G-CSF: Grannulocyte-colony stimulating factor; Location: Ut: upper third of the esophagus; Mt: middle side of the esophagus; Lt: lower third of the esophagus; Ae: abdominal esophagus; Type: mavroscopic classification; 0Ip: polypoid type; Type 2: ulcerative and localized type; Type3: ulcerative and infiltrated type; Size: cm in length; T: depth of invasion; T1: invasion to but not beyond the submucosa; T2: invasion to but not beyond the muscularis propria; T3: invasion to the esophageal adventitia; T4: invasion to the adjacent organ;
not mentioned; Immuno-st: Immunohistochemical study.
Source . | Age . | Sex . | Symptom . | Tumor markers . | G- CSF . | Location . | Type . | Size . | T . | N . | M . | IM . | IDG . | Stage . | Therapy . | Type (H) . | Immuno-st . | Rec . | Outcome . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEA . | SCC . | Op . | Chemo . | RT . | Ca . | Sa . | ||||||||||||||||||
Saitou H et al. Nippon Rinsho Geka Gakkai Zasshi 58: 1023–6. | 80 | M | dysphagia | * | * | (–) | Mt | 1 | * | * | * | * | * | (–) | * | evulsion | (–) | (–) | so-called | * | * | * | * | * |
Arima M et al. I to Cho 30: 1437–44. | 47 | M | Anemia | 0.69 | 0.82 | (–) | Mt | 0IIc | 5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | EMA | * | (–) | 54 | Alive |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 50 | M | dysphagia | * | * | (–) | Mt | 1 | 9 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 53 | Dead |
Ohhashi S et al. Gastroenterological endoscopy 37: 1162–7. | 53 | F | dysphagia | * | * | (–) | Lt | I + IIa + IIc | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | * | KL, EMA | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 55 | M | chest pain | * | * | (–) | Mt | 0Ip | 2.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | KL | VIM | (–) | 14 | Alive |
Kanamoto A et al. Arch Pathol Laboratory Medical 124: 1685–7. | 55 | M | dysphagia | * | * | (–) | Lt | 0Ip | 1.5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | pseudo | KL | SMA | (–) | 33 | Alive |
Gomi T et al. Kokuritsu Himeji Byouin Kiyo 7: 13–6. | 61 | M | dysphagia | 3.4 | 0.7 | (–) | Lt | 0Ip | 13 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | authentic | * | VIM | (–) | 12 | Alive |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 58: 586–90. | 63 | M | g.f. | * | * | (+) | Mt | 1 | 3.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | Trans: KL, EMA | (–) | 2 | Alive | |
Suzuki K et al. Tokyo Joshi Ikadaigaku Zasshi 65: 109–13. | 66 | M | dysphagia | 1.3 | * | (–) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | * | * | (–) | 12 | Dead |
Ohkura Y. Byori to Rinsho 20: 489–95. | 68 | M | dysphagia | * | * | (–) | Ut | 0Ip | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)pre | (+)pre | so-called | * | Kl | (–) | 8 | Dead |
Saeki H et al. Shokakigeka 24: 1665–71. | 68 | M | * | * | * | (–) | Mt | 0Ip | * | 1b | 0 | 0 | 0 | (–) | I | * | * | * | authentic | * | * | * | * | * |
Kitazono M et al. Nippon Shokaki Geka Gakkai Zasshi 30: 1922–6. | 68 | M | dysphagia | * | * | (–) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (+) | I | Par | (–) | (–) | so-called | * | VIM | * | * | * |
Morimoto Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 3036–40. | 70 | M | fever | * | * | (–) | Mt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | evulsion | (–) | (–) | so-called | * | VIM, SMA | (–) | 12 | Alive |
Nakanowatari M et al. Akitaken Noson Igakkai Zasshi 49: 58–61. | 71 | M | dysphagia | 6.4 | 15 | (–) | Mt | 0Ip | 5 | 1a | 0 | 0 | 0 | (–) | I | EMR | * | * | so-called | KL | SMA | (–) | 1 | Dead |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1094–7. | 76 | M | dysphagia | 6.3 | 1.1 | (+) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL | VIM | LN | 12 | Dead |
Machida A et al. Showa Igakkai Zasshi 64: 321–5. | 78 | M | dysphagia | * | * | (–) | Mt | 0Ip | 8.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)post | (–) | pseudo | * | VIM | lung | 27 | Alive |
Takabayashi N et al. Gann no Rinsho 50: 315–9. | 79 | M | vomiting | * | * | (–) | Lt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM | (–) | 23 | Alive |
Shibazaki H et al. Nippon Rinsho Geka Gakkai Zasshi 63: 2920–5. | 79 | M | dysphagia | * | * | (+) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL, SMA | VIM | (–) | 10 | Alive |
Kawada S et al. Geka 61: 337–40. | 83 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | KL | KL | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 84 | M | dysphagia | * | * | (–) | Mt | 0Ip | 5.5 | 1b | 0 | 0 | 0 | (–) | I | evulsion | * | * | authentic | KL | SMA | (–) | 24 | Alive |
Minakawa Y et al. Teikyou Igaku Zasshi 25: 441–8. | 50 | M | dysphagia | 3.2 | 0.5 | (–) | Mt | 0Ip | 15 | 1b | 2 | 0 | 0 | (+) | II | Sub | (+)post | (–) | so-called | KL, EMA | KL, VIM | (–) | 46 | Alive |
Daiwan C et al. Okinawa Igakkai Zasshi 35: 95–8. | 50 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 2.7 | 2 | 0 | 0 | 0 | (–) | II | Sub | * | * | so-called | * | KL | * | * | * |
Shibata K et al. Nippon Rinsho Geka Gakkai Zasshi 59: 967–71. | 51 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4.5 | 2 | 0 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | EMA | Local | 24 | Alive |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 53 | M | dysphagia | * | * | (–) | Lt | 0Ip | * | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 2 | Dead |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 55 | M | dysphagia | * | * | (–) | Mt | 1 | 14 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | Local | 9 | Dead |
Andou T et al. Shujutsu 58: 1353–6. | 56 | M | dysphagia | 4.1 | * | (–) | Mt | 0Ip | 14.5 | 2 | 1 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | * | (–) | 6 | Alive |
Ohshiro N et al. Nippon Shokaki Geka Gakkai Zasshi 32: 2350–4. | 56 | M | dysphagia | 5.7 | 0.9 | (+) | Lt | 0Ip | 6 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | (–) | 8 | Alive |
Yoshida K et al. Nippon Rinsho Geka Gakkai Zasshi 57: 2295–9. | 56 | M | chest pain | * | * | (–) | Ut | 0Ip | 8 | 2 | 0 | 0 | 0 | (+) | II | Par | (+)post | (–) | so-called | * | * | Local | 10 | Dead |
Hayashi S et al. Gastroenterological endoscopy 38: 2188–99. | 58 | M | dysphagia | 5.1 | 0.53 | (–) | Mt | 1 | 18 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | SMA | (–) | 12 | Alive |
Matsui K et al. Tottori Igaku Zasshi 23: 275–81. | 59 | M | dysphagia | 0.4 | * | (–) | Mt | 3 | 12 | 2 | 0 | 0 | 0 | (+) | II | Total | (–) | (–) | authentic | EMA, KL | VIM | penitoneal | 15 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 59 | M | dysphagia | * | * | (–) | Lt | 1 | 8 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | EMA, VIM | (–) | 6 | Alive |
Asai H et al. Nippon Shokaki Geka Gakkai Zasshi 36: 464–9. | 60 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 2 | 0 | 0 | (–) | II | Sub | (+)pre | (–) | so-called | KL | SMA | (–) | 12 | Alive |
Ohtaka M et al. Pathology Int 52: 657–63. | 61 | M | dysphagia | * | * | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | * | * | * |
Shimura T et al. Nipon Shokaki Naishikyou Gakkai Zassi 46: 253–8. | 62 | M | dysphagia | 0.7 | 0.7 | (–) | Lt | 1 | 8.5 | 2 | 1 | 0 | 0 | (–) | II | Par | * | * | so-called | * | * | * | * | * |
Isogai K et al. Shokaki Naishikyou 13: 243–5. | 64 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 5.5 | 1b | 2 | 0 | 1 | (–) | II | Sub | * | * | so-called | KL | VIM | (–) | 12 | Alive |
Ohtsuka Y et al. Progress of Digestive Endoscopy 54: 102–3. | 67 | M | none | 9.2 | 3.1 | (–) | Mt | 0Ip | 3.5 | 2 | 0 | 0 | 0 | (–) | II | sub | (+)pre | (–) | pseudo | EMA | VIM | * | * | * |
Shimooki O et al. Nippon Kyoubu Geka Gakkai Zasshi 43: 1942–7. | 67 | M | g.f. | * | * | (–) | Mt | 0Ip | 10.5 | 1 | 1 | 0 | 0 | (+) | II | Total | (+)post | (–) | so-called | * | EMA | (–) | 18 | Alive |
Miyake M et al. Gann no Rinsho 49: 127–31. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 6 | 3 | 0 | 0 | 0 | (–) | II | (–) | (+) | (+) | so-called | * | * | (–) | 3 | Alive |
Harada Y. Rinsho Shokaki Naika 15: 585–9. | 68 | M | none | * | * | (–) | Mt | 0Ip | 3 | 1a | 1 | 0 | 0 | (–) | II | Sub | (+)post | (+)post | so-called | * | KL, VIM | (–) | * | * |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 10.5 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 5 | Alive |
Sawamura T et al. Geka 56: 1112–4. | 71 | F | dysphagia | * | 0.9 | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 48 | Alive |
Takemura M et al. Shokakigeka 24: 363–7. | 79 | M | chest pain | 2 | 0.9 | (–) | Mt | 0Ip | 2 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, VIM | Brain | 11 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 79 | M | chest pain | * | * | (–) | Mt | 0Ip | 3 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, Vim | Brain | 17 | Dead |
Moriyama Y et al. Nippon Geka Rengoukei Gakkaishi 24: 216–21. | 54 | M | dysphagia | * | * | (–) | Lt | 3 | 7 | 3 | 2 | 0 | 0 | (–) | III | Total | * | (+)post | so-called | KL | VIM | (+) | 30 | Dead |
Miyazaki K et al. Rinsho to Kenkyuu 78: 713–6. | 57 | M | dysphagia | 1.5 | * | (–) | Mt | 0Ip | 7 | 3 | 1 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 7 | Alive |
Kagawa N et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1098–102. | 60 | M | dysphagia | * | * | (–) | Mt | 1 | 13 | 2 | 2 | 0 | 0 | (+) | III | Sub | (+)pre | (+)pre | so-called | * | AE1,3 | LN | 6 | Dead |
Tkatani Y et al. Nippon Rinsho Geka Gakkai Zasshi 63: 1683–7. | 62 | F | dysphagia | 0.5 | 3.3 | (–) | Mt | 0Ip | 6 | 2 | 3 | 0 | 0 | (+) | III | Sub | (+)post | (–) | so-called | KL, VIM | SMA | H, LM | 37 | Dead |
Akutsu Y et al. Gann no Rinsho 44: 96–101. | 62 | M | dysphagia | * | * | (+) | Mt | 1 | 7 | 3 | 0 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | KL | * | Local | 11 | Dead |
Horimoto M et al. Gastroenterological Endoscopy 41: 2051–7. | 65 | M | dysphagia | 1.9 | 0.5 | (–) | Mt | 0Ip | 8 | 2 | 2 | 0 | 0 | (–) | III | Sub | * | * | so-called | KL | VIM | (–) | 10 | Alive |
Hosodani Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 122–6. | 71 | M | dysphagia | * | 1.8 | (–) | Ut | 1 | 8 | 2 | 3 | 0 | 0 | (–) | III | Sub | (–) | (+)post | so-called | EMA, KL | EMA, VIM | (–) | 9 | Alive |
Iyama H et al. Endoscopic Forum for Digestive Disease 14: 12–7. | 77 | M | dysphagia | 3.9 | 6.1 | (–) | Lt | 0Ip | 5 | 2 | 2 | 0 | 1 | (–) | III | Sub | * | * | so-called | * | KL | * | * | * |
Ohmi R et al. Nippon Rinsho Geka Gakkai Zasshi 60: 97–101. | 59 | M | chest pain | 3.1 | 6.5 | (–) | Mt | 1 | 11 | 2 | 4 | 0 | 0 | (–) | IV a | Sub | (–) | (–) | authentic | KL, EMA | SMA | (–) | 26 | Alive |
Kubota S et al. Surg Today 29: 777–81. | 60 | M | dysphagia | * | * | (–) | Mt | 3 | 10 | 4 | 2 | 0 | 0 | (–) | IV a | Sub | (+)post | (–) | pseudo | KL | VIM | (–) | 10 | Alive |
Sonoda N et al. Gastroenterological endoscopy 41: 42–8. | 63 | M | dysphagia | 1.8 | 0.8 | (–) | Ae | 2 | 4.5 | 3 | 3 | 0 | 0 | (–) | IV a | Par | * | * | authentic | KL | VIM | * | * | * |
Kohara Y et al. Gann no Rinsho 40: 977–82. | 65 | M | dysphagia | 5.7 | 1.2 | (–) | Ut | 0Ip | 3.5 | 1b | 4 | 0 | 0 | (–) | IV a | Total | (+)post | (+)post | so-called | KL | VIM | Skin, Local | 12 | Dead |
Kishimoto H et al. Geka 64: 713–6. | 67 | M | dysphagia | 0.9 | 2.8 | (–) | Lt | 3 | 10 | 3 | 4 | 0 | 1 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | VIM, EMA | LN | 4 | Dead |
Satou Y et al. Akitaken Noson Igakkai Zasshi 39: 11–6. | 66 | M | fever | * | * | (–) | Mt | 0Ip | 14 | 1b | 3 | 0 | 0 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | * | lung | 27 | Dead |
Source . | Age . | Sex . | Symptom . | Tumor markers . | G- CSF . | Location . | Type . | Size . | T . | N . | M . | IM . | IDG . | Stage . | Therapy . | Type (H) . | Immuno-st . | Rec . | Outcome . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEA . | SCC . | Op . | Chemo . | RT . | Ca . | Sa . | ||||||||||||||||||
Saitou H et al. Nippon Rinsho Geka Gakkai Zasshi 58: 1023–6. | 80 | M | dysphagia | * | * | (–) | Mt | 1 | * | * | * | * | * | (–) | * | evulsion | (–) | (–) | so-called | * | * | * | * | * |
Arima M et al. I to Cho 30: 1437–44. | 47 | M | Anemia | 0.69 | 0.82 | (–) | Mt | 0IIc | 5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | EMA | * | (–) | 54 | Alive |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 50 | M | dysphagia | * | * | (–) | Mt | 1 | 9 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 53 | Dead |
Ohhashi S et al. Gastroenterological endoscopy 37: 1162–7. | 53 | F | dysphagia | * | * | (–) | Lt | I + IIa + IIc | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | * | KL, EMA | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 55 | M | chest pain | * | * | (–) | Mt | 0Ip | 2.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | KL | VIM | (–) | 14 | Alive |
Kanamoto A et al. Arch Pathol Laboratory Medical 124: 1685–7. | 55 | M | dysphagia | * | * | (–) | Lt | 0Ip | 1.5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | pseudo | KL | SMA | (–) | 33 | Alive |
Gomi T et al. Kokuritsu Himeji Byouin Kiyo 7: 13–6. | 61 | M | dysphagia | 3.4 | 0.7 | (–) | Lt | 0Ip | 13 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | authentic | * | VIM | (–) | 12 | Alive |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 58: 586–90. | 63 | M | g.f. | * | * | (+) | Mt | 1 | 3.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | Trans: KL, EMA | (–) | 2 | Alive | |
Suzuki K et al. Tokyo Joshi Ikadaigaku Zasshi 65: 109–13. | 66 | M | dysphagia | 1.3 | * | (–) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | * | * | (–) | 12 | Dead |
Ohkura Y. Byori to Rinsho 20: 489–95. | 68 | M | dysphagia | * | * | (–) | Ut | 0Ip | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)pre | (+)pre | so-called | * | Kl | (–) | 8 | Dead |
Saeki H et al. Shokakigeka 24: 1665–71. | 68 | M | * | * | * | (–) | Mt | 0Ip | * | 1b | 0 | 0 | 0 | (–) | I | * | * | * | authentic | * | * | * | * | * |
Kitazono M et al. Nippon Shokaki Geka Gakkai Zasshi 30: 1922–6. | 68 | M | dysphagia | * | * | (–) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (+) | I | Par | (–) | (–) | so-called | * | VIM | * | * | * |
Morimoto Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 3036–40. | 70 | M | fever | * | * | (–) | Mt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | evulsion | (–) | (–) | so-called | * | VIM, SMA | (–) | 12 | Alive |
Nakanowatari M et al. Akitaken Noson Igakkai Zasshi 49: 58–61. | 71 | M | dysphagia | 6.4 | 15 | (–) | Mt | 0Ip | 5 | 1a | 0 | 0 | 0 | (–) | I | EMR | * | * | so-called | KL | SMA | (–) | 1 | Dead |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1094–7. | 76 | M | dysphagia | 6.3 | 1.1 | (+) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL | VIM | LN | 12 | Dead |
Machida A et al. Showa Igakkai Zasshi 64: 321–5. | 78 | M | dysphagia | * | * | (–) | Mt | 0Ip | 8.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)post | (–) | pseudo | * | VIM | lung | 27 | Alive |
Takabayashi N et al. Gann no Rinsho 50: 315–9. | 79 | M | vomiting | * | * | (–) | Lt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM | (–) | 23 | Alive |
Shibazaki H et al. Nippon Rinsho Geka Gakkai Zasshi 63: 2920–5. | 79 | M | dysphagia | * | * | (+) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL, SMA | VIM | (–) | 10 | Alive |
Kawada S et al. Geka 61: 337–40. | 83 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | KL | KL | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 84 | M | dysphagia | * | * | (–) | Mt | 0Ip | 5.5 | 1b | 0 | 0 | 0 | (–) | I | evulsion | * | * | authentic | KL | SMA | (–) | 24 | Alive |
Minakawa Y et al. Teikyou Igaku Zasshi 25: 441–8. | 50 | M | dysphagia | 3.2 | 0.5 | (–) | Mt | 0Ip | 15 | 1b | 2 | 0 | 0 | (+) | II | Sub | (+)post | (–) | so-called | KL, EMA | KL, VIM | (–) | 46 | Alive |
Daiwan C et al. Okinawa Igakkai Zasshi 35: 95–8. | 50 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 2.7 | 2 | 0 | 0 | 0 | (–) | II | Sub | * | * | so-called | * | KL | * | * | * |
Shibata K et al. Nippon Rinsho Geka Gakkai Zasshi 59: 967–71. | 51 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4.5 | 2 | 0 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | EMA | Local | 24 | Alive |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 53 | M | dysphagia | * | * | (–) | Lt | 0Ip | * | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 2 | Dead |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 55 | M | dysphagia | * | * | (–) | Mt | 1 | 14 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | Local | 9 | Dead |
Andou T et al. Shujutsu 58: 1353–6. | 56 | M | dysphagia | 4.1 | * | (–) | Mt | 0Ip | 14.5 | 2 | 1 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | * | (–) | 6 | Alive |
Ohshiro N et al. Nippon Shokaki Geka Gakkai Zasshi 32: 2350–4. | 56 | M | dysphagia | 5.7 | 0.9 | (+) | Lt | 0Ip | 6 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | (–) | 8 | Alive |
Yoshida K et al. Nippon Rinsho Geka Gakkai Zasshi 57: 2295–9. | 56 | M | chest pain | * | * | (–) | Ut | 0Ip | 8 | 2 | 0 | 0 | 0 | (+) | II | Par | (+)post | (–) | so-called | * | * | Local | 10 | Dead |
Hayashi S et al. Gastroenterological endoscopy 38: 2188–99. | 58 | M | dysphagia | 5.1 | 0.53 | (–) | Mt | 1 | 18 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | SMA | (–) | 12 | Alive |
Matsui K et al. Tottori Igaku Zasshi 23: 275–81. | 59 | M | dysphagia | 0.4 | * | (–) | Mt | 3 | 12 | 2 | 0 | 0 | 0 | (+) | II | Total | (–) | (–) | authentic | EMA, KL | VIM | penitoneal | 15 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 59 | M | dysphagia | * | * | (–) | Lt | 1 | 8 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | EMA, VIM | (–) | 6 | Alive |
Asai H et al. Nippon Shokaki Geka Gakkai Zasshi 36: 464–9. | 60 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 2 | 0 | 0 | (–) | II | Sub | (+)pre | (–) | so-called | KL | SMA | (–) | 12 | Alive |
Ohtaka M et al. Pathology Int 52: 657–63. | 61 | M | dysphagia | * | * | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | * | * | * |
Shimura T et al. Nipon Shokaki Naishikyou Gakkai Zassi 46: 253–8. | 62 | M | dysphagia | 0.7 | 0.7 | (–) | Lt | 1 | 8.5 | 2 | 1 | 0 | 0 | (–) | II | Par | * | * | so-called | * | * | * | * | * |
Isogai K et al. Shokaki Naishikyou 13: 243–5. | 64 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 5.5 | 1b | 2 | 0 | 1 | (–) | II | Sub | * | * | so-called | KL | VIM | (–) | 12 | Alive |
Ohtsuka Y et al. Progress of Digestive Endoscopy 54: 102–3. | 67 | M | none | 9.2 | 3.1 | (–) | Mt | 0Ip | 3.5 | 2 | 0 | 0 | 0 | (–) | II | sub | (+)pre | (–) | pseudo | EMA | VIM | * | * | * |
Shimooki O et al. Nippon Kyoubu Geka Gakkai Zasshi 43: 1942–7. | 67 | M | g.f. | * | * | (–) | Mt | 0Ip | 10.5 | 1 | 1 | 0 | 0 | (+) | II | Total | (+)post | (–) | so-called | * | EMA | (–) | 18 | Alive |
Miyake M et al. Gann no Rinsho 49: 127–31. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 6 | 3 | 0 | 0 | 0 | (–) | II | (–) | (+) | (+) | so-called | * | * | (–) | 3 | Alive |
Harada Y. Rinsho Shokaki Naika 15: 585–9. | 68 | M | none | * | * | (–) | Mt | 0Ip | 3 | 1a | 1 | 0 | 0 | (–) | II | Sub | (+)post | (+)post | so-called | * | KL, VIM | (–) | * | * |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 10.5 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 5 | Alive |
Sawamura T et al. Geka 56: 1112–4. | 71 | F | dysphagia | * | 0.9 | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 48 | Alive |
Takemura M et al. Shokakigeka 24: 363–7. | 79 | M | chest pain | 2 | 0.9 | (–) | Mt | 0Ip | 2 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, VIM | Brain | 11 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 79 | M | chest pain | * | * | (–) | Mt | 0Ip | 3 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, Vim | Brain | 17 | Dead |
Moriyama Y et al. Nippon Geka Rengoukei Gakkaishi 24: 216–21. | 54 | M | dysphagia | * | * | (–) | Lt | 3 | 7 | 3 | 2 | 0 | 0 | (–) | III | Total | * | (+)post | so-called | KL | VIM | (+) | 30 | Dead |
Miyazaki K et al. Rinsho to Kenkyuu 78: 713–6. | 57 | M | dysphagia | 1.5 | * | (–) | Mt | 0Ip | 7 | 3 | 1 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 7 | Alive |
Kagawa N et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1098–102. | 60 | M | dysphagia | * | * | (–) | Mt | 1 | 13 | 2 | 2 | 0 | 0 | (+) | III | Sub | (+)pre | (+)pre | so-called | * | AE1,3 | LN | 6 | Dead |
Tkatani Y et al. Nippon Rinsho Geka Gakkai Zasshi 63: 1683–7. | 62 | F | dysphagia | 0.5 | 3.3 | (–) | Mt | 0Ip | 6 | 2 | 3 | 0 | 0 | (+) | III | Sub | (+)post | (–) | so-called | KL, VIM | SMA | H, LM | 37 | Dead |
Akutsu Y et al. Gann no Rinsho 44: 96–101. | 62 | M | dysphagia | * | * | (+) | Mt | 1 | 7 | 3 | 0 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | KL | * | Local | 11 | Dead |
Horimoto M et al. Gastroenterological Endoscopy 41: 2051–7. | 65 | M | dysphagia | 1.9 | 0.5 | (–) | Mt | 0Ip | 8 | 2 | 2 | 0 | 0 | (–) | III | Sub | * | * | so-called | KL | VIM | (–) | 10 | Alive |
Hosodani Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 122–6. | 71 | M | dysphagia | * | 1.8 | (–) | Ut | 1 | 8 | 2 | 3 | 0 | 0 | (–) | III | Sub | (–) | (+)post | so-called | EMA, KL | EMA, VIM | (–) | 9 | Alive |
Iyama H et al. Endoscopic Forum for Digestive Disease 14: 12–7. | 77 | M | dysphagia | 3.9 | 6.1 | (–) | Lt | 0Ip | 5 | 2 | 2 | 0 | 1 | (–) | III | Sub | * | * | so-called | * | KL | * | * | * |
Ohmi R et al. Nippon Rinsho Geka Gakkai Zasshi 60: 97–101. | 59 | M | chest pain | 3.1 | 6.5 | (–) | Mt | 1 | 11 | 2 | 4 | 0 | 0 | (–) | IV a | Sub | (–) | (–) | authentic | KL, EMA | SMA | (–) | 26 | Alive |
Kubota S et al. Surg Today 29: 777–81. | 60 | M | dysphagia | * | * | (–) | Mt | 3 | 10 | 4 | 2 | 0 | 0 | (–) | IV a | Sub | (+)post | (–) | pseudo | KL | VIM | (–) | 10 | Alive |
Sonoda N et al. Gastroenterological endoscopy 41: 42–8. | 63 | M | dysphagia | 1.8 | 0.8 | (–) | Ae | 2 | 4.5 | 3 | 3 | 0 | 0 | (–) | IV a | Par | * | * | authentic | KL | VIM | * | * | * |
Kohara Y et al. Gann no Rinsho 40: 977–82. | 65 | M | dysphagia | 5.7 | 1.2 | (–) | Ut | 0Ip | 3.5 | 1b | 4 | 0 | 0 | (–) | IV a | Total | (+)post | (+)post | so-called | KL | VIM | Skin, Local | 12 | Dead |
Kishimoto H et al. Geka 64: 713–6. | 67 | M | dysphagia | 0.9 | 2.8 | (–) | Lt | 3 | 10 | 3 | 4 | 0 | 1 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | VIM, EMA | LN | 4 | Dead |
Satou Y et al. Akitaken Noson Igakkai Zasshi 39: 11–6. | 66 | M | fever | * | * | (–) | Mt | 0Ip | 14 | 1b | 3 | 0 | 0 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | * | lung | 27 | Dead |
Sex: M: male; F: female; Symptom: g.f.: general fatigue; CEA: carcinoembryonic antigen; SCC: squamous cell carcinoma associated antigen; G-CSF: Grannulocyte-colony stimulating factor; Location: Ut: upper third of the esophagus; Mt: middle side of the esophagus; Lt: lower third of the esophagus; Ae: abdominal esophagus; Type: mavroscopic classification; 0Ip: polypoid type; Type 2: ulcerative and localized type; Type3: ulcerative and infiltrated type; Size: cm in length; T: depth of invasion; T1: invasion to but not beyond the submucosa; T2: invasion to but not beyond the muscularis propria; T3: invasion to the esophageal adventitia; T4: invasion to the adjacent organ;
not mentioned; Immuno-st: Immunohistochemical study.
Source . | Age . | Sex . | Symptom . | tumor markers . | G- CSF . | Location . | Type . | Size . | T . | N . | M . | IM . | IDG . | Stage . | Therapy . | Type (H) . | Immuno-st . | Rec . | Outcome . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEA . | SCC . | Op . | Chemo . | RT . | Ca . | Sa . | ||||||||||||||||||
Saitou H et al. Nippon Rinsho Geka Gakkai Zasshi 58: 1023–6. | 80 | M | dysphagia | * | * | (–) | Mt | 1 | * | * | * | * | * | (–) | * | evulsion | (–) | (–) | so-called | * | * | * | * | * |
Arima M et al. I to Cho 30: 1437–44. | 47 | M | Anemia | 0.69 | 0.82 | (–) | Mt | 0IIc | 5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | EMA | * | (–) | 54 | Alive |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 50 | M | dysphagia | * | * | (–) | Mt | 1 | 9 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 53 | Dead |
Ohhashi S et al. Gastroenterological endoscopy 37: 1162–7. | 53 | F | dysphagia | * | * | (–) | Lt | I + IIa + IIc | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | * | KL, EMA | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 55 | M | chest pain | * | * | (–) | Mt | 0Ip | 2.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | KL | VIM | (–) | 14 | Alive |
Kanamoto A et al. Arch Pathol Laboratory Medical 124: 1685–7. | 55 | M | dysphagia | * | * | (–) | Lt | 0Ip | 1.5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | pseudo | KL | SMA | (–) | 33 | Alive |
Gomi T et al. Kokuritsu Himeji Byouin Kiyo 7: 13–6. | 61 | M | dysphagia | 3.4 | 0.7 | (–) | Lt | 0Ip | 13 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | authentic | * | VIM | (–) | 12 | Alive |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 58: 586–90. | 63 | M | g.f. | * | * | (+) | Mt | 1 | 3.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | Trans: KL, EMA | (–) | 2 | Alive | |
Suzuki K et al. Tokyo Joshi Ikadaigaku Zasshi 65: 109–13. | 66 | M | dysphagia | 1.3 | * | (–) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | * | * | (–) | 12 | Dead |
Ohkura Y. Byori to Rinsho 20: 489–95. | 68 | M | dysphagia | * | * | (–) | Ut | 0Ip | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)pre | (+)pre | so-called | * | Kl | (–) | 8 | Dead |
Saeki H et al. Shokakigeka 24: 1665–71. | 68 | M | * | * | * | (–) | Mt | 0Ip | * | 1b | 0 | 0 | 0 | (–) | I | * | * | * | authentic | * | * | * | * | * |
Kitazono M et al. Nippon Shokaki Geka Gakkai Zasshi 30: 1922–6. | 68 | M | dysphagia | * | * | (–) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (+) | I | Par | (–) | (–) | so-called | * | VIM | * | * | * |
Morimoto Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 3036–40. | 70 | M | fever | * | * | (–) | Mt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | evulsion | (–) | (–) | so-called | * | VIM, SMA | (–) | 12 | Alive |
Nakanowatari M et al. Akitaken Noson Igakkai Zasshi 49: 58–61. | 71 | M | dysphagia | 6.4 | 15 | (–) | Mt | 0Ip | 5 | 1a | 0 | 0 | 0 | (–) | I | EMR | * | * | so-called | KL | SMA | (–) | 1 | Dead |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1094–7. | 76 | M | dysphagia | 6.3 | 1.1 | (+) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL | VIM | LN | 12 | Dead |
Machida A et al. Showa Igakkai Zasshi 64: 321–5. | 78 | M | dysphagia | * | * | (–) | Mt | 0Ip | 8.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)post | (–) | pseudo | * | VIM | lung | 27 | Alive |
Takabayashi N et al. Gann no Rinsho 50: 315–9. | 79 | M | vomiting | * | * | (–) | Lt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM | (–) | 23 | Alive |
Shibazaki H et al. Nippon Rinsho Geka Gakkai Zasshi 63: 2920–5. | 79 | M | dysphagia | * | * | (+) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL, SMA | VIM | (–) | 10 | Alive |
Kawada S et al. Geka 61: 337–40. | 83 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | KL | KL | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 84 | M | dysphagia | * | * | (–) | Mt | 0Ip | 5.5 | 1b | 0 | 0 | 0 | (–) | I | evulsion | * | * | authentic | KL | SMA | (–) | 24 | Alive |
Minakawa Y et al. Teikyou Igaku Zasshi 25: 441–8. | 50 | M | dysphagia | 3.2 | 0.5 | (–) | Mt | 0Ip | 15 | 1b | 2 | 0 | 0 | (+) | II | Sub | (+)post | (–) | so-called | KL, EMA | KL, VIM | (–) | 46 | Alive |
Daiwan C et al. Okinawa Igakkai Zasshi 35: 95–8. | 50 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 2.7 | 2 | 0 | 0 | 0 | (–) | II | Sub | * | * | so-called | * | KL | * | * | * |
Shibata K et al. Nippon Rinsho Geka Gakkai Zasshi 59: 967–71. | 51 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4.5 | 2 | 0 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | EMA | Local | 24 | Alive |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 53 | M | dysphagia | * | * | (–) | Lt | 0Ip | * | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 2 | Dead |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 55 | M | dysphagia | * | * | (–) | Mt | 1 | 14 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | Local | 9 | Dead |
Andou T et al. Shujutsu 58: 1353–6. | 56 | M | dysphagia | 4.1 | * | (–) | Mt | 0Ip | 14.5 | 2 | 1 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | * | (–) | 6 | Alive |
Ohshiro N et al. Nippon Shokaki Geka Gakkai Zasshi 32: 2350–4. | 56 | M | dysphagia | 5.7 | 0.9 | (+) | Lt | 0Ip | 6 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | (–) | 8 | Alive |
Yoshida K et al. Nippon Rinsho Geka Gakkai Zasshi 57: 2295–9. | 56 | M | chest pain | * | * | (–) | Ut | 0Ip | 8 | 2 | 0 | 0 | 0 | (+) | II | Par | (+)post | (–) | so-called | * | * | Local | 10 | Dead |
Hayashi S et al. Gastroenterological endoscopy 38: 2188–99. | 58 | M | dysphagia | 5.1 | 0.53 | (–) | Mt | 1 | 18 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | SMA | (–) | 12 | Alive |
Matsui K et al. Tottori Igaku Zasshi 23: 275–81. | 59 | M | dysphagia | 0.4 | * | (–) | Mt | 3 | 12 | 2 | 0 | 0 | 0 | (+) | II | Total | (–) | (–) | authentic | EMA, KL | VIM | penitoneal | 15 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 59 | M | dysphagia | * | * | (–) | Lt | 1 | 8 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | EMA, VIM | (–) | 6 | Alive |
Asai H et al. Nippon Shokaki Geka Gakkai Zasshi 36: 464–9. | 60 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 2 | 0 | 0 | (–) | II | Sub | (+)pre | (–) | so-called | KL | SMA | (–) | 12 | Alive |
Ohtaka M et al. Pathology Int 52: 657–63. | 61 | M | dysphagia | * | * | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | * | * | * |
Shimura T et al. Nipon Shokaki Naishikyou Gakkai Zassi 46: 253–8. | 62 | M | dysphagia | 0.7 | 0.7 | (–) | Lt | 1 | 8.5 | 2 | 1 | 0 | 0 | (–) | II | Par | * | * | so-called | * | * | * | * | * |
Isogai K et al. Shokaki Naishikyou 13: 243–5. | 64 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 5.5 | 1b | 2 | 0 | 1 | (–) | II | Sub | * | * | so-called | KL | VIM | (–) | 12 | Alive |
Ohtsuka Y et al. Progress of Digestive Endoscopy 54: 102–3. | 67 | M | none | 9.2 | 3.1 | (–) | Mt | 0Ip | 3.5 | 2 | 0 | 0 | 0 | (–) | II | sub | (+)pre | (–) | pseudo | EMA | VIM | * | * | * |
Shimooki O et al. Nippon Kyoubu Geka Gakkai Zasshi 43: 1942–7. | 67 | M | g.f. | * | * | (–) | Mt | 0Ip | 10.5 | 1 | 1 | 0 | 0 | (+) | II | Total | (+)post | (–) | so-called | * | EMA | (–) | 18 | Alive |
Miyake M et al. Gann no Rinsho 49: 127–31. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 6 | 3 | 0 | 0 | 0 | (–) | II | (–) | (+) | (+) | so-called | * | * | (–) | 3 | Alive |
Harada Y. Rinsho Shokaki Naika 15: 585–9. | 68 | M | none | * | * | (–) | Mt | 0Ip | 3 | 1a | 1 | 0 | 0 | (–) | II | Sub | (+)post | (+)post | so-called | * | KL, VIM | (–) | * | * |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 10.5 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 5 | Alive |
Sawamura T et al. Geka 56: 1112–4. | 71 | F | dysphagia | * | 0.9 | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 48 | Alive |
Takemura M et al. Shokakigeka 24: 363–7. | 79 | M | chest pain | 2 | 0.9 | (–) | Mt | 0Ip | 2 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, VIM | Brain | 11 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 79 | M | chest pain | * | * | (–) | Mt | 0Ip | 3 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, Vim | Brain | 17 | Dead |
Moriyama Y et al. Nippon Geka Rengoukei Gakkaishi 24: 216–21. | 54 | M | dysphagia | * | * | (–) | Lt | 3 | 7 | 3 | 2 | 0 | 0 | (–) | III | Total | * | (+)post | so-called | KL | VIM | (+) | 30 | Dead |
Miyazaki K et al. Rinsho to Kenkyuu 78: 713–6. | 57 | M | dysphagia | 1.5 | * | (–) | Mt | 0Ip | 7 | 3 | 1 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 7 | Alive |
Kagawa N et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1098–102. | 60 | M | dysphagia | * | * | (–) | Mt | 1 | 13 | 2 | 2 | 0 | 0 | (+) | III | Sub | (+)pre | (+)pre | so-called | * | AE1,3 | LN | 6 | Dead |
Tkatani Y et al. Nippon Rinsho Geka Gakkai Zasshi 63: 1683–7. | 62 | F | dysphagia | 0.5 | 3.3 | (–) | Mt | 0Ip | 6 | 2 | 3 | 0 | 0 | (+) | III | Sub | (+)post | (–) | so-called | KL, VIM | SMA | H, LM | 37 | Dead |
Akutsu Y et al. Gann no Rinsho 44: 96–101. | 62 | M | dysphagia | * | * | (+) | Mt | 1 | 7 | 3 | 0 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | KL | * | Local | 11 | Dead |
Horimoto M et al. Gastroenterological Endoscopy 41: 2051–7. | 65 | M | dysphagia | 1.9 | 0.5 | (–) | Mt | 0Ip | 8 | 2 | 2 | 0 | 0 | (–) | III | Sub | * | * | so-called | KL | VIM | (–) | 10 | Alive |
Hosodani Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 122–6. | 71 | M | dysphagia | * | 1.8 | (–) | Ut | 1 | 8 | 2 | 3 | 0 | 0 | (–) | III | Sub | (–) | (+)post | so-called | EMA, KL | EMA, VIM | (–) | 9 | Alive |
Iyama H et al. Endoscopic Forum for Digestive Disease 14: 12–7. | 77 | M | dysphagia | 3.9 | 6.1 | (–) | Lt | 0Ip | 5 | 2 | 2 | 0 | 1 | (–) | III | Sub | * | * | so-called | * | KL | * | * | * |
Ohmi R et al. Nippon Rinsho Geka Gakkai Zasshi 60: 97–101. | 59 | M | chest pain | 3.1 | 6.5 | (–) | Mt | 1 | 11 | 2 | 4 | 0 | 0 | (–) | IV a | Sub | (–) | (–) | authentic | KL, EMA | SMA | (–) | 26 | Alive |
Kubota S et al. Surg Today 29: 777–81. | 60 | M | dysphagia | * | * | (–) | Mt | 3 | 10 | 4 | 2 | 0 | 0 | (–) | IV a | Sub | (+)post | (–) | pseudo | KL | VIM | (–) | 10 | Alive |
Sonoda N et al. Gastroenterological endoscopy 41: 42–8. | 63 | M | dysphagia | 1.8 | 0.8 | (–) | Ae | 2 | 4.5 | 3 | 3 | 0 | 0 | (–) | IV a | Par | * | * | authentic | KL | VIM | * | * | * |
Kohara Y et al. Gann no Rinsho 40: 977–82. | 65 | M | dysphagia | 5.7 | 1.2 | (–) | Ut | 0Ip | 3.5 | 1b | 4 | 0 | 0 | (–) | IV a | Total | (+)post | (+)post | so-called | KL | VIM | Skin, Local | 12 | Dead |
Kishimoto H et al. Geka 64: 713–6. | 67 | M | dysphagia | 0.9 | 2.8 | (–) | Lt | 3 | 10 | 3 | 4 | 0 | 1 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | VIM, EMA | LN | 4 | Dead |
Satou Y et al. Akitaken Noson Igakkai Zasshi 39: 11–6. | 66 | M | fever | * | * | (–) | Mt | 0Ip | 14 | 1b | 3 | 0 | 0 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | * | lung | 27 | Dead |
Source . | Age . | Sex . | Symptom . | tumor markers . | G- CSF . | Location . | Type . | Size . | T . | N . | M . | IM . | IDG . | Stage . | Therapy . | Type (H) . | Immuno-st . | Rec . | Outcome . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEA . | SCC . | Op . | Chemo . | RT . | Ca . | Sa . | ||||||||||||||||||
Saitou H et al. Nippon Rinsho Geka Gakkai Zasshi 58: 1023–6. | 80 | M | dysphagia | * | * | (–) | Mt | 1 | * | * | * | * | * | (–) | * | evulsion | (–) | (–) | so-called | * | * | * | * | * |
Arima M et al. I to Cho 30: 1437–44. | 47 | M | Anemia | 0.69 | 0.82 | (–) | Mt | 0IIc | 5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | EMA | * | (–) | 54 | Alive |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 50 | M | dysphagia | * | * | (–) | Mt | 1 | 9 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 53 | Dead |
Ohhashi S et al. Gastroenterological endoscopy 37: 1162–7. | 53 | F | dysphagia | * | * | (–) | Lt | I + IIa + IIc | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | * | KL, EMA | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 55 | M | chest pain | * | * | (–) | Mt | 0Ip | 2.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | KL | VIM | (–) | 14 | Alive |
Kanamoto A et al. Arch Pathol Laboratory Medical 124: 1685–7. | 55 | M | dysphagia | * | * | (–) | Lt | 0Ip | 1.5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | pseudo | KL | SMA | (–) | 33 | Alive |
Gomi T et al. Kokuritsu Himeji Byouin Kiyo 7: 13–6. | 61 | M | dysphagia | 3.4 | 0.7 | (–) | Lt | 0Ip | 13 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | authentic | * | VIM | (–) | 12 | Alive |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 58: 586–90. | 63 | M | g.f. | * | * | (+) | Mt | 1 | 3.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | Trans: KL, EMA | (–) | 2 | Alive | |
Suzuki K et al. Tokyo Joshi Ikadaigaku Zasshi 65: 109–13. | 66 | M | dysphagia | 1.3 | * | (–) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | * | * | (–) | 12 | Dead |
Ohkura Y. Byori to Rinsho 20: 489–95. | 68 | M | dysphagia | * | * | (–) | Ut | 0Ip | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)pre | (+)pre | so-called | * | Kl | (–) | 8 | Dead |
Saeki H et al. Shokakigeka 24: 1665–71. | 68 | M | * | * | * | (–) | Mt | 0Ip | * | 1b | 0 | 0 | 0 | (–) | I | * | * | * | authentic | * | * | * | * | * |
Kitazono M et al. Nippon Shokaki Geka Gakkai Zasshi 30: 1922–6. | 68 | M | dysphagia | * | * | (–) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (+) | I | Par | (–) | (–) | so-called | * | VIM | * | * | * |
Morimoto Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 3036–40. | 70 | M | fever | * | * | (–) | Mt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | evulsion | (–) | (–) | so-called | * | VIM, SMA | (–) | 12 | Alive |
Nakanowatari M et al. Akitaken Noson Igakkai Zasshi 49: 58–61. | 71 | M | dysphagia | 6.4 | 15 | (–) | Mt | 0Ip | 5 | 1a | 0 | 0 | 0 | (–) | I | EMR | * | * | so-called | KL | SMA | (–) | 1 | Dead |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1094–7. | 76 | M | dysphagia | 6.3 | 1.1 | (+) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL | VIM | LN | 12 | Dead |
Machida A et al. Showa Igakkai Zasshi 64: 321–5. | 78 | M | dysphagia | * | * | (–) | Mt | 0Ip | 8.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)post | (–) | pseudo | * | VIM | lung | 27 | Alive |
Takabayashi N et al. Gann no Rinsho 50: 315–9. | 79 | M | vomiting | * | * | (–) | Lt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM | (–) | 23 | Alive |
Shibazaki H et al. Nippon Rinsho Geka Gakkai Zasshi 63: 2920–5. | 79 | M | dysphagia | * | * | (+) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL, SMA | VIM | (–) | 10 | Alive |
Kawada S et al. Geka 61: 337–40. | 83 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | KL | KL | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 84 | M | dysphagia | * | * | (–) | Mt | 0Ip | 5.5 | 1b | 0 | 0 | 0 | (–) | I | evulsion | * | * | authentic | KL | SMA | (–) | 24 | Alive |
Minakawa Y et al. Teikyou Igaku Zasshi 25: 441–8. | 50 | M | dysphagia | 3.2 | 0.5 | (–) | Mt | 0Ip | 15 | 1b | 2 | 0 | 0 | (+) | II | Sub | (+)post | (–) | so-called | KL, EMA | KL, VIM | (–) | 46 | Alive |
Daiwan C et al. Okinawa Igakkai Zasshi 35: 95–8. | 50 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 2.7 | 2 | 0 | 0 | 0 | (–) | II | Sub | * | * | so-called | * | KL | * | * | * |
Shibata K et al. Nippon Rinsho Geka Gakkai Zasshi 59: 967–71. | 51 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4.5 | 2 | 0 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | EMA | Local | 24 | Alive |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 53 | M | dysphagia | * | * | (–) | Lt | 0Ip | * | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 2 | Dead |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 55 | M | dysphagia | * | * | (–) | Mt | 1 | 14 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | Local | 9 | Dead |
Andou T et al. Shujutsu 58: 1353–6. | 56 | M | dysphagia | 4.1 | * | (–) | Mt | 0Ip | 14.5 | 2 | 1 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | * | (–) | 6 | Alive |
Ohshiro N et al. Nippon Shokaki Geka Gakkai Zasshi 32: 2350–4. | 56 | M | dysphagia | 5.7 | 0.9 | (+) | Lt | 0Ip | 6 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | (–) | 8 | Alive |
Yoshida K et al. Nippon Rinsho Geka Gakkai Zasshi 57: 2295–9. | 56 | M | chest pain | * | * | (–) | Ut | 0Ip | 8 | 2 | 0 | 0 | 0 | (+) | II | Par | (+)post | (–) | so-called | * | * | Local | 10 | Dead |
Hayashi S et al. Gastroenterological endoscopy 38: 2188–99. | 58 | M | dysphagia | 5.1 | 0.53 | (–) | Mt | 1 | 18 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | SMA | (–) | 12 | Alive |
Matsui K et al. Tottori Igaku Zasshi 23: 275–81. | 59 | M | dysphagia | 0.4 | * | (–) | Mt | 3 | 12 | 2 | 0 | 0 | 0 | (+) | II | Total | (–) | (–) | authentic | EMA, KL | VIM | penitoneal | 15 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 59 | M | dysphagia | * | * | (–) | Lt | 1 | 8 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | EMA, VIM | (–) | 6 | Alive |
Asai H et al. Nippon Shokaki Geka Gakkai Zasshi 36: 464–9. | 60 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 2 | 0 | 0 | (–) | II | Sub | (+)pre | (–) | so-called | KL | SMA | (–) | 12 | Alive |
Ohtaka M et al. Pathology Int 52: 657–63. | 61 | M | dysphagia | * | * | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | * | * | * |
Shimura T et al. Nipon Shokaki Naishikyou Gakkai Zassi 46: 253–8. | 62 | M | dysphagia | 0.7 | 0.7 | (–) | Lt | 1 | 8.5 | 2 | 1 | 0 | 0 | (–) | II | Par | * | * | so-called | * | * | * | * | * |
Isogai K et al. Shokaki Naishikyou 13: 243–5. | 64 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 5.5 | 1b | 2 | 0 | 1 | (–) | II | Sub | * | * | so-called | KL | VIM | (–) | 12 | Alive |
Ohtsuka Y et al. Progress of Digestive Endoscopy 54: 102–3. | 67 | M | none | 9.2 | 3.1 | (–) | Mt | 0Ip | 3.5 | 2 | 0 | 0 | 0 | (–) | II | sub | (+)pre | (–) | pseudo | EMA | VIM | * | * | * |
Shimooki O et al. Nippon Kyoubu Geka Gakkai Zasshi 43: 1942–7. | 67 | M | g.f. | * | * | (–) | Mt | 0Ip | 10.5 | 1 | 1 | 0 | 0 | (+) | II | Total | (+)post | (–) | so-called | * | EMA | (–) | 18 | Alive |
Miyake M et al. Gann no Rinsho 49: 127–31. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 6 | 3 | 0 | 0 | 0 | (–) | II | (–) | (+) | (+) | so-called | * | * | (–) | 3 | Alive |
Harada Y. Rinsho Shokaki Naika 15: 585–9. | 68 | M | none | * | * | (–) | Mt | 0Ip | 3 | 1a | 1 | 0 | 0 | (–) | II | Sub | (+)post | (+)post | so-called | * | KL, VIM | (–) | * | * |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 10.5 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 5 | Alive |
Sawamura T et al. Geka 56: 1112–4. | 71 | F | dysphagia | * | 0.9 | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 48 | Alive |
Takemura M et al. Shokakigeka 24: 363–7. | 79 | M | chest pain | 2 | 0.9 | (–) | Mt | 0Ip | 2 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, VIM | Brain | 11 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 79 | M | chest pain | * | * | (–) | Mt | 0Ip | 3 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, Vim | Brain | 17 | Dead |
Moriyama Y et al. Nippon Geka Rengoukei Gakkaishi 24: 216–21. | 54 | M | dysphagia | * | * | (–) | Lt | 3 | 7 | 3 | 2 | 0 | 0 | (–) | III | Total | * | (+)post | so-called | KL | VIM | (+) | 30 | Dead |
Miyazaki K et al. Rinsho to Kenkyuu 78: 713–6. | 57 | M | dysphagia | 1.5 | * | (–) | Mt | 0Ip | 7 | 3 | 1 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 7 | Alive |
Kagawa N et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1098–102. | 60 | M | dysphagia | * | * | (–) | Mt | 1 | 13 | 2 | 2 | 0 | 0 | (+) | III | Sub | (+)pre | (+)pre | so-called | * | AE1,3 | LN | 6 | Dead |
Tkatani Y et al. Nippon Rinsho Geka Gakkai Zasshi 63: 1683–7. | 62 | F | dysphagia | 0.5 | 3.3 | (–) | Mt | 0Ip | 6 | 2 | 3 | 0 | 0 | (+) | III | Sub | (+)post | (–) | so-called | KL, VIM | SMA | H, LM | 37 | Dead |
Akutsu Y et al. Gann no Rinsho 44: 96–101. | 62 | M | dysphagia | * | * | (+) | Mt | 1 | 7 | 3 | 0 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | KL | * | Local | 11 | Dead |
Horimoto M et al. Gastroenterological Endoscopy 41: 2051–7. | 65 | M | dysphagia | 1.9 | 0.5 | (–) | Mt | 0Ip | 8 | 2 | 2 | 0 | 0 | (–) | III | Sub | * | * | so-called | KL | VIM | (–) | 10 | Alive |
Hosodani Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 122–6. | 71 | M | dysphagia | * | 1.8 | (–) | Ut | 1 | 8 | 2 | 3 | 0 | 0 | (–) | III | Sub | (–) | (+)post | so-called | EMA, KL | EMA, VIM | (–) | 9 | Alive |
Iyama H et al. Endoscopic Forum for Digestive Disease 14: 12–7. | 77 | M | dysphagia | 3.9 | 6.1 | (–) | Lt | 0Ip | 5 | 2 | 2 | 0 | 1 | (–) | III | Sub | * | * | so-called | * | KL | * | * | * |
Ohmi R et al. Nippon Rinsho Geka Gakkai Zasshi 60: 97–101. | 59 | M | chest pain | 3.1 | 6.5 | (–) | Mt | 1 | 11 | 2 | 4 | 0 | 0 | (–) | IV a | Sub | (–) | (–) | authentic | KL, EMA | SMA | (–) | 26 | Alive |
Kubota S et al. Surg Today 29: 777–81. | 60 | M | dysphagia | * | * | (–) | Mt | 3 | 10 | 4 | 2 | 0 | 0 | (–) | IV a | Sub | (+)post | (–) | pseudo | KL | VIM | (–) | 10 | Alive |
Sonoda N et al. Gastroenterological endoscopy 41: 42–8. | 63 | M | dysphagia | 1.8 | 0.8 | (–) | Ae | 2 | 4.5 | 3 | 3 | 0 | 0 | (–) | IV a | Par | * | * | authentic | KL | VIM | * | * | * |
Kohara Y et al. Gann no Rinsho 40: 977–82. | 65 | M | dysphagia | 5.7 | 1.2 | (–) | Ut | 0Ip | 3.5 | 1b | 4 | 0 | 0 | (–) | IV a | Total | (+)post | (+)post | so-called | KL | VIM | Skin, Local | 12 | Dead |
Kishimoto H et al. Geka 64: 713–6. | 67 | M | dysphagia | 0.9 | 2.8 | (–) | Lt | 3 | 10 | 3 | 4 | 0 | 1 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | VIM, EMA | LN | 4 | Dead |
Satou Y et al. Akitaken Noson Igakkai Zasshi 39: 11–6. | 66 | M | fever | * | * | (–) | Mt | 0Ip | 14 | 1b | 3 | 0 | 0 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | * | lung | 27 | Dead |
N: lymph node metastasis; N0: no lymph node metastasis; N1: metastasis to group 1 lymph node; N2: metastasis to group 2 lymph node; N3: metastasis to group 3 lymph node; N4: metastasis to group 4 lymph node; M: distant organ metastasis; M0: absence; M1: presence; IM: intramural metastasis; IDG: Superficial extension; Stage: histologic stage; Op: operation; Sub: subtotal esophagectomy; Tot: total esophagectomy; Par: partial esophagectomy; evulsion: esophagectomy without thoracotomy; chemo: chemotherapy; pre: preoperative; post: postoperative; RT: radiation; Type (H): histologic classification; Immuno-st: immunohistochemical study; c. carcinoma components; sa: sarcoma components; KL: keratin; Rec: recurrence; H: liver; LM: lung; Outcome: month/dead or alive;
not mentioned.
Source . | Age . | Sex . | Symptom . | tumor markers . | G- CSF . | Location . | Type . | Size . | T . | N . | M . | IM . | IDG . | Stage . | Therapy . | Type (H) . | Immuno-st . | Rec . | Outcome . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEA . | SCC . | Op . | Chemo . | RT . | Ca . | Sa . | ||||||||||||||||||
Saitou H et al. Nippon Rinsho Geka Gakkai Zasshi 58: 1023–6. | 80 | M | dysphagia | * | * | (–) | Mt | 1 | * | * | * | * | * | (–) | * | evulsion | (–) | (–) | so-called | * | * | * | * | * |
Arima M et al. I to Cho 30: 1437–44. | 47 | M | Anemia | 0.69 | 0.82 | (–) | Mt | 0IIc | 5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | EMA | * | (–) | 54 | Alive |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 50 | M | dysphagia | * | * | (–) | Mt | 1 | 9 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 53 | Dead |
Ohhashi S et al. Gastroenterological endoscopy 37: 1162–7. | 53 | F | dysphagia | * | * | (–) | Lt | I + IIa + IIc | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | * | KL, EMA | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 55 | M | chest pain | * | * | (–) | Mt | 0Ip | 2.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | KL | VIM | (–) | 14 | Alive |
Kanamoto A et al. Arch Pathol Laboratory Medical 124: 1685–7. | 55 | M | dysphagia | * | * | (–) | Lt | 0Ip | 1.5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | pseudo | KL | SMA | (–) | 33 | Alive |
Gomi T et al. Kokuritsu Himeji Byouin Kiyo 7: 13–6. | 61 | M | dysphagia | 3.4 | 0.7 | (–) | Lt | 0Ip | 13 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | authentic | * | VIM | (–) | 12 | Alive |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 58: 586–90. | 63 | M | g.f. | * | * | (+) | Mt | 1 | 3.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | Trans: KL, EMA | (–) | 2 | Alive | |
Suzuki K et al. Tokyo Joshi Ikadaigaku Zasshi 65: 109–13. | 66 | M | dysphagia | 1.3 | * | (–) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | * | * | (–) | 12 | Dead |
Ohkura Y. Byori to Rinsho 20: 489–95. | 68 | M | dysphagia | * | * | (–) | Ut | 0Ip | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)pre | (+)pre | so-called | * | Kl | (–) | 8 | Dead |
Saeki H et al. Shokakigeka 24: 1665–71. | 68 | M | * | * | * | (–) | Mt | 0Ip | * | 1b | 0 | 0 | 0 | (–) | I | * | * | * | authentic | * | * | * | * | * |
Kitazono M et al. Nippon Shokaki Geka Gakkai Zasshi 30: 1922–6. | 68 | M | dysphagia | * | * | (–) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (+) | I | Par | (–) | (–) | so-called | * | VIM | * | * | * |
Morimoto Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 3036–40. | 70 | M | fever | * | * | (–) | Mt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | evulsion | (–) | (–) | so-called | * | VIM, SMA | (–) | 12 | Alive |
Nakanowatari M et al. Akitaken Noson Igakkai Zasshi 49: 58–61. | 71 | M | dysphagia | 6.4 | 15 | (–) | Mt | 0Ip | 5 | 1a | 0 | 0 | 0 | (–) | I | EMR | * | * | so-called | KL | SMA | (–) | 1 | Dead |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1094–7. | 76 | M | dysphagia | 6.3 | 1.1 | (+) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL | VIM | LN | 12 | Dead |
Machida A et al. Showa Igakkai Zasshi 64: 321–5. | 78 | M | dysphagia | * | * | (–) | Mt | 0Ip | 8.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)post | (–) | pseudo | * | VIM | lung | 27 | Alive |
Takabayashi N et al. Gann no Rinsho 50: 315–9. | 79 | M | vomiting | * | * | (–) | Lt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM | (–) | 23 | Alive |
Shibazaki H et al. Nippon Rinsho Geka Gakkai Zasshi 63: 2920–5. | 79 | M | dysphagia | * | * | (+) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL, SMA | VIM | (–) | 10 | Alive |
Kawada S et al. Geka 61: 337–40. | 83 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | KL | KL | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 84 | M | dysphagia | * | * | (–) | Mt | 0Ip | 5.5 | 1b | 0 | 0 | 0 | (–) | I | evulsion | * | * | authentic | KL | SMA | (–) | 24 | Alive |
Minakawa Y et al. Teikyou Igaku Zasshi 25: 441–8. | 50 | M | dysphagia | 3.2 | 0.5 | (–) | Mt | 0Ip | 15 | 1b | 2 | 0 | 0 | (+) | II | Sub | (+)post | (–) | so-called | KL, EMA | KL, VIM | (–) | 46 | Alive |
Daiwan C et al. Okinawa Igakkai Zasshi 35: 95–8. | 50 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 2.7 | 2 | 0 | 0 | 0 | (–) | II | Sub | * | * | so-called | * | KL | * | * | * |
Shibata K et al. Nippon Rinsho Geka Gakkai Zasshi 59: 967–71. | 51 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4.5 | 2 | 0 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | EMA | Local | 24 | Alive |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 53 | M | dysphagia | * | * | (–) | Lt | 0Ip | * | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 2 | Dead |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 55 | M | dysphagia | * | * | (–) | Mt | 1 | 14 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | Local | 9 | Dead |
Andou T et al. Shujutsu 58: 1353–6. | 56 | M | dysphagia | 4.1 | * | (–) | Mt | 0Ip | 14.5 | 2 | 1 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | * | (–) | 6 | Alive |
Ohshiro N et al. Nippon Shokaki Geka Gakkai Zasshi 32: 2350–4. | 56 | M | dysphagia | 5.7 | 0.9 | (+) | Lt | 0Ip | 6 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | (–) | 8 | Alive |
Yoshida K et al. Nippon Rinsho Geka Gakkai Zasshi 57: 2295–9. | 56 | M | chest pain | * | * | (–) | Ut | 0Ip | 8 | 2 | 0 | 0 | 0 | (+) | II | Par | (+)post | (–) | so-called | * | * | Local | 10 | Dead |
Hayashi S et al. Gastroenterological endoscopy 38: 2188–99. | 58 | M | dysphagia | 5.1 | 0.53 | (–) | Mt | 1 | 18 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | SMA | (–) | 12 | Alive |
Matsui K et al. Tottori Igaku Zasshi 23: 275–81. | 59 | M | dysphagia | 0.4 | * | (–) | Mt | 3 | 12 | 2 | 0 | 0 | 0 | (+) | II | Total | (–) | (–) | authentic | EMA, KL | VIM | penitoneal | 15 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 59 | M | dysphagia | * | * | (–) | Lt | 1 | 8 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | EMA, VIM | (–) | 6 | Alive |
Asai H et al. Nippon Shokaki Geka Gakkai Zasshi 36: 464–9. | 60 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 2 | 0 | 0 | (–) | II | Sub | (+)pre | (–) | so-called | KL | SMA | (–) | 12 | Alive |
Ohtaka M et al. Pathology Int 52: 657–63. | 61 | M | dysphagia | * | * | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | * | * | * |
Shimura T et al. Nipon Shokaki Naishikyou Gakkai Zassi 46: 253–8. | 62 | M | dysphagia | 0.7 | 0.7 | (–) | Lt | 1 | 8.5 | 2 | 1 | 0 | 0 | (–) | II | Par | * | * | so-called | * | * | * | * | * |
Isogai K et al. Shokaki Naishikyou 13: 243–5. | 64 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 5.5 | 1b | 2 | 0 | 1 | (–) | II | Sub | * | * | so-called | KL | VIM | (–) | 12 | Alive |
Ohtsuka Y et al. Progress of Digestive Endoscopy 54: 102–3. | 67 | M | none | 9.2 | 3.1 | (–) | Mt | 0Ip | 3.5 | 2 | 0 | 0 | 0 | (–) | II | sub | (+)pre | (–) | pseudo | EMA | VIM | * | * | * |
Shimooki O et al. Nippon Kyoubu Geka Gakkai Zasshi 43: 1942–7. | 67 | M | g.f. | * | * | (–) | Mt | 0Ip | 10.5 | 1 | 1 | 0 | 0 | (+) | II | Total | (+)post | (–) | so-called | * | EMA | (–) | 18 | Alive |
Miyake M et al. Gann no Rinsho 49: 127–31. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 6 | 3 | 0 | 0 | 0 | (–) | II | (–) | (+) | (+) | so-called | * | * | (–) | 3 | Alive |
Harada Y. Rinsho Shokaki Naika 15: 585–9. | 68 | M | none | * | * | (–) | Mt | 0Ip | 3 | 1a | 1 | 0 | 0 | (–) | II | Sub | (+)post | (+)post | so-called | * | KL, VIM | (–) | * | * |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 10.5 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 5 | Alive |
Sawamura T et al. Geka 56: 1112–4. | 71 | F | dysphagia | * | 0.9 | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 48 | Alive |
Takemura M et al. Shokakigeka 24: 363–7. | 79 | M | chest pain | 2 | 0.9 | (–) | Mt | 0Ip | 2 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, VIM | Brain | 11 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 79 | M | chest pain | * | * | (–) | Mt | 0Ip | 3 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, Vim | Brain | 17 | Dead |
Moriyama Y et al. Nippon Geka Rengoukei Gakkaishi 24: 216–21. | 54 | M | dysphagia | * | * | (–) | Lt | 3 | 7 | 3 | 2 | 0 | 0 | (–) | III | Total | * | (+)post | so-called | KL | VIM | (+) | 30 | Dead |
Miyazaki K et al. Rinsho to Kenkyuu 78: 713–6. | 57 | M | dysphagia | 1.5 | * | (–) | Mt | 0Ip | 7 | 3 | 1 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 7 | Alive |
Kagawa N et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1098–102. | 60 | M | dysphagia | * | * | (–) | Mt | 1 | 13 | 2 | 2 | 0 | 0 | (+) | III | Sub | (+)pre | (+)pre | so-called | * | AE1,3 | LN | 6 | Dead |
Tkatani Y et al. Nippon Rinsho Geka Gakkai Zasshi 63: 1683–7. | 62 | F | dysphagia | 0.5 | 3.3 | (–) | Mt | 0Ip | 6 | 2 | 3 | 0 | 0 | (+) | III | Sub | (+)post | (–) | so-called | KL, VIM | SMA | H, LM | 37 | Dead |
Akutsu Y et al. Gann no Rinsho 44: 96–101. | 62 | M | dysphagia | * | * | (+) | Mt | 1 | 7 | 3 | 0 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | KL | * | Local | 11 | Dead |
Horimoto M et al. Gastroenterological Endoscopy 41: 2051–7. | 65 | M | dysphagia | 1.9 | 0.5 | (–) | Mt | 0Ip | 8 | 2 | 2 | 0 | 0 | (–) | III | Sub | * | * | so-called | KL | VIM | (–) | 10 | Alive |
Hosodani Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 122–6. | 71 | M | dysphagia | * | 1.8 | (–) | Ut | 1 | 8 | 2 | 3 | 0 | 0 | (–) | III | Sub | (–) | (+)post | so-called | EMA, KL | EMA, VIM | (–) | 9 | Alive |
Iyama H et al. Endoscopic Forum for Digestive Disease 14: 12–7. | 77 | M | dysphagia | 3.9 | 6.1 | (–) | Lt | 0Ip | 5 | 2 | 2 | 0 | 1 | (–) | III | Sub | * | * | so-called | * | KL | * | * | * |
Ohmi R et al. Nippon Rinsho Geka Gakkai Zasshi 60: 97–101. | 59 | M | chest pain | 3.1 | 6.5 | (–) | Mt | 1 | 11 | 2 | 4 | 0 | 0 | (–) | IV a | Sub | (–) | (–) | authentic | KL, EMA | SMA | (–) | 26 | Alive |
Kubota S et al. Surg Today 29: 777–81. | 60 | M | dysphagia | * | * | (–) | Mt | 3 | 10 | 4 | 2 | 0 | 0 | (–) | IV a | Sub | (+)post | (–) | pseudo | KL | VIM | (–) | 10 | Alive |
Sonoda N et al. Gastroenterological endoscopy 41: 42–8. | 63 | M | dysphagia | 1.8 | 0.8 | (–) | Ae | 2 | 4.5 | 3 | 3 | 0 | 0 | (–) | IV a | Par | * | * | authentic | KL | VIM | * | * | * |
Kohara Y et al. Gann no Rinsho 40: 977–82. | 65 | M | dysphagia | 5.7 | 1.2 | (–) | Ut | 0Ip | 3.5 | 1b | 4 | 0 | 0 | (–) | IV a | Total | (+)post | (+)post | so-called | KL | VIM | Skin, Local | 12 | Dead |
Kishimoto H et al. Geka 64: 713–6. | 67 | M | dysphagia | 0.9 | 2.8 | (–) | Lt | 3 | 10 | 3 | 4 | 0 | 1 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | VIM, EMA | LN | 4 | Dead |
Satou Y et al. Akitaken Noson Igakkai Zasshi 39: 11–6. | 66 | M | fever | * | * | (–) | Mt | 0Ip | 14 | 1b | 3 | 0 | 0 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | * | lung | 27 | Dead |
Source . | Age . | Sex . | Symptom . | tumor markers . | G- CSF . | Location . | Type . | Size . | T . | N . | M . | IM . | IDG . | Stage . | Therapy . | Type (H) . | Immuno-st . | Rec . | Outcome . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEA . | SCC . | Op . | Chemo . | RT . | Ca . | Sa . | ||||||||||||||||||
Saitou H et al. Nippon Rinsho Geka Gakkai Zasshi 58: 1023–6. | 80 | M | dysphagia | * | * | (–) | Mt | 1 | * | * | * | * | * | (–) | * | evulsion | (–) | (–) | so-called | * | * | * | * | * |
Arima M et al. I to Cho 30: 1437–44. | 47 | M | Anemia | 0.69 | 0.82 | (–) | Mt | 0IIc | 5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | EMA | * | (–) | 54 | Alive |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 50 | M | dysphagia | * | * | (–) | Mt | 1 | 9 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 53 | Dead |
Ohhashi S et al. Gastroenterological endoscopy 37: 1162–7. | 53 | F | dysphagia | * | * | (–) | Lt | I + IIa + IIc | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | * | KL, EMA | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 55 | M | chest pain | * | * | (–) | Mt | 0Ip | 2.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | KL | VIM | (–) | 14 | Alive |
Kanamoto A et al. Arch Pathol Laboratory Medical 124: 1685–7. | 55 | M | dysphagia | * | * | (–) | Lt | 0Ip | 1.5 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | pseudo | KL | SMA | (–) | 33 | Alive |
Gomi T et al. Kokuritsu Himeji Byouin Kiyo 7: 13–6. | 61 | M | dysphagia | 3.4 | 0.7 | (–) | Lt | 0Ip | 13 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | authentic | * | VIM | (–) | 12 | Alive |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 58: 586–90. | 63 | M | g.f. | * | * | (+) | Mt | 1 | 3.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | Trans: KL, EMA | (–) | 2 | Alive | |
Suzuki K et al. Tokyo Joshi Ikadaigaku Zasshi 65: 109–13. | 66 | M | dysphagia | 1.3 | * | (–) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | * | * | so-called | * | * | (–) | 12 | Dead |
Ohkura Y. Byori to Rinsho 20: 489–95. | 68 | M | dysphagia | * | * | (–) | Ut | 0Ip | 4.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)pre | (+)pre | so-called | * | Kl | (–) | 8 | Dead |
Saeki H et al. Shokakigeka 24: 1665–71. | 68 | M | * | * | * | (–) | Mt | 0Ip | * | 1b | 0 | 0 | 0 | (–) | I | * | * | * | authentic | * | * | * | * | * |
Kitazono M et al. Nippon Shokaki Geka Gakkai Zasshi 30: 1922–6. | 68 | M | dysphagia | * | * | (–) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (+) | I | Par | (–) | (–) | so-called | * | VIM | * | * | * |
Morimoto Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 3036–40. | 70 | M | fever | * | * | (–) | Mt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | evulsion | (–) | (–) | so-called | * | VIM, SMA | (–) | 12 | Alive |
Nakanowatari M et al. Akitaken Noson Igakkai Zasshi 49: 58–61. | 71 | M | dysphagia | 6.4 | 15 | (–) | Mt | 0Ip | 5 | 1a | 0 | 0 | 0 | (–) | I | EMR | * | * | so-called | KL | SMA | (–) | 1 | Dead |
Fujimori M et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1094–7. | 76 | M | dysphagia | 6.3 | 1.1 | (+) | Mt | 0Ip | 11.5 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL | VIM | LN | 12 | Dead |
Machida A et al. Showa Igakkai Zasshi 64: 321–5. | 78 | M | dysphagia | * | * | (–) | Mt | 0Ip | 8.5 | 1b | 0 | 0 | 0 | (–) | I | Sub | (+)post | (–) | pseudo | * | VIM | lung | 27 | Alive |
Takabayashi N et al. Gann no Rinsho 50: 315–9. | 79 | M | vomiting | * | * | (–) | Lt | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Sub | (–) | (–) | so-called | KL, EMA | VIM | (–) | 23 | Alive |
Shibazaki H et al. Nippon Rinsho Geka Gakkai Zasshi 63: 2920–5. | 79 | M | dysphagia | * | * | (+) | Ae | 0Ip | 8 | 1b | 0 | 0 | 0 | (–) | I | Par | (–) | (–) | so-called | KL, SMA | VIM | (–) | 10 | Alive |
Kawada S et al. Geka 61: 337–40. | 83 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 0 | 0 | 0 | (+) | I | Sub | (–) | (–) | so-called | KL | KL | * | * | * |
Taniyama K et al. Pathology Int 45: 297–302. | 84 | M | dysphagia | * | * | (–) | Mt | 0Ip | 5.5 | 1b | 0 | 0 | 0 | (–) | I | evulsion | * | * | authentic | KL | SMA | (–) | 24 | Alive |
Minakawa Y et al. Teikyou Igaku Zasshi 25: 441–8. | 50 | M | dysphagia | 3.2 | 0.5 | (–) | Mt | 0Ip | 15 | 1b | 2 | 0 | 0 | (+) | II | Sub | (+)post | (–) | so-called | KL, EMA | KL, VIM | (–) | 46 | Alive |
Daiwan C et al. Okinawa Igakkai Zasshi 35: 95–8. | 50 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 2.7 | 2 | 0 | 0 | 0 | (–) | II | Sub | * | * | so-called | * | KL | * | * | * |
Shibata K et al. Nippon Rinsho Geka Gakkai Zasshi 59: 967–71. | 51 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4.5 | 2 | 0 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | EMA | Local | 24 | Alive |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 53 | M | dysphagia | * | * | (–) | Lt | 0Ip | * | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 2 | Dead |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 55 | M | dysphagia | * | * | (–) | Mt | 1 | 14 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | Local | 9 | Dead |
Andou T et al. Shujutsu 58: 1353–6. | 56 | M | dysphagia | 4.1 | * | (–) | Mt | 0Ip | 14.5 | 2 | 1 | 0 | 0 | (+) | II | Sub | (–) | (–) | so-called | * | * | (–) | 6 | Alive |
Ohshiro N et al. Nippon Shokaki Geka Gakkai Zasshi 32: 2350–4. | 56 | M | dysphagia | 5.7 | 0.9 | (+) | Lt | 0Ip | 6 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | (–) | 8 | Alive |
Yoshida K et al. Nippon Rinsho Geka Gakkai Zasshi 57: 2295–9. | 56 | M | chest pain | * | * | (–) | Ut | 0Ip | 8 | 2 | 0 | 0 | 0 | (+) | II | Par | (+)post | (–) | so-called | * | * | Local | 10 | Dead |
Hayashi S et al. Gastroenterological endoscopy 38: 2188–99. | 58 | M | dysphagia | 5.1 | 0.53 | (–) | Mt | 1 | 18 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | SMA | (–) | 12 | Alive |
Matsui K et al. Tottori Igaku Zasshi 23: 275–81. | 59 | M | dysphagia | 0.4 | * | (–) | Mt | 3 | 12 | 2 | 0 | 0 | 0 | (+) | II | Total | (–) | (–) | authentic | EMA, KL | VIM | penitoneal | 15 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 59 | M | dysphagia | * | * | (–) | Lt | 1 | 8 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | EMA, VIM | (–) | 6 | Alive |
Asai H et al. Nippon Shokaki Geka Gakkai Zasshi 36: 464–9. | 60 | M | dysphagia | * | * | (–) | Mt | 0Ip | 4 | 1b | 2 | 0 | 0 | (–) | II | Sub | (+)pre | (–) | so-called | KL | SMA | (–) | 12 | Alive |
Ohtaka M et al. Pathology Int 52: 657–63. | 61 | M | dysphagia | * | * | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | * | * | * | * |
Shimura T et al. Nipon Shokaki Naishikyou Gakkai Zassi 46: 253–8. | 62 | M | dysphagia | 0.7 | 0.7 | (–) | Lt | 1 | 8.5 | 2 | 1 | 0 | 0 | (–) | II | Par | * | * | so-called | * | * | * | * | * |
Isogai K et al. Shokaki Naishikyou 13: 243–5. | 64 | F | dysphagia | * | * | (–) | Mt | 0Ip + IIc | 5.5 | 1b | 2 | 0 | 1 | (–) | II | Sub | * | * | so-called | KL | VIM | (–) | 12 | Alive |
Ohtsuka Y et al. Progress of Digestive Endoscopy 54: 102–3. | 67 | M | none | 9.2 | 3.1 | (–) | Mt | 0Ip | 3.5 | 2 | 0 | 0 | 0 | (–) | II | sub | (+)pre | (–) | pseudo | EMA | VIM | * | * | * |
Shimooki O et al. Nippon Kyoubu Geka Gakkai Zasshi 43: 1942–7. | 67 | M | g.f. | * | * | (–) | Mt | 0Ip | 10.5 | 1 | 1 | 0 | 0 | (+) | II | Total | (+)post | (–) | so-called | * | EMA | (–) | 18 | Alive |
Miyake M et al. Gann no Rinsho 49: 127–31. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 6 | 3 | 0 | 0 | 0 | (–) | II | (–) | (+) | (+) | so-called | * | * | (–) | 3 | Alive |
Harada Y. Rinsho Shokaki Naika 15: 585–9. | 68 | M | none | * | * | (–) | Mt | 0Ip | 3 | 1a | 1 | 0 | 0 | (–) | II | Sub | (+)post | (+)post | so-called | * | KL, VIM | (–) | * | * |
Aimoto T et al. Gann no Rinsho 43: 919–23. | 68 | M | dysphagia | * | * | (–) | Mt | 1 | 10.5 | 2 | 0 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | KL, EMA | VIM, SMA | (–) | 5 | Alive |
Sawamura T et al. Geka 56: 1112–4. | 71 | F | dysphagia | * | 0.9 | (–) | Mt | 1 | 16 | 1b | 1 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 48 | Alive |
Takemura M et al. Shokakigeka 24: 363–7. | 79 | M | chest pain | 2 | 0.9 | (–) | Mt | 0Ip | 2 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, VIM | Brain | 11 | Dead |
Takemura M et al. Nipponn Rinsho geka Gakkai Zasshi 62: 659–64. | 79 | M | chest pain | * | * | (–) | Mt | 0Ip | 3 | 1b | 2 | 0 | 0 | (–) | II | Sub | (–) | (–) | so-called | * | KL, Vim | Brain | 17 | Dead |
Moriyama Y et al. Nippon Geka Rengoukei Gakkaishi 24: 216–21. | 54 | M | dysphagia | * | * | (–) | Lt | 3 | 7 | 3 | 2 | 0 | 0 | (–) | III | Total | * | (+)post | so-called | KL | VIM | (+) | 30 | Dead |
Miyazaki K et al. Rinsho to Kenkyuu 78: 713–6. | 57 | M | dysphagia | 1.5 | * | (–) | Mt | 0Ip | 7 | 3 | 1 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | * | KL, EMA | (–) | 7 | Alive |
Kagawa N et al. Nippon Rinsho Geka Gakkai Zasshi 64: 1098–102. | 60 | M | dysphagia | * | * | (–) | Mt | 1 | 13 | 2 | 2 | 0 | 0 | (+) | III | Sub | (+)pre | (+)pre | so-called | * | AE1,3 | LN | 6 | Dead |
Tkatani Y et al. Nippon Rinsho Geka Gakkai Zasshi 63: 1683–7. | 62 | F | dysphagia | 0.5 | 3.3 | (–) | Mt | 0Ip | 6 | 2 | 3 | 0 | 0 | (+) | III | Sub | (+)post | (–) | so-called | KL, VIM | SMA | H, LM | 37 | Dead |
Akutsu Y et al. Gann no Rinsho 44: 96–101. | 62 | M | dysphagia | * | * | (+) | Mt | 1 | 7 | 3 | 0 | 0 | 0 | (–) | III | Sub | (–) | (–) | so-called | KL | * | Local | 11 | Dead |
Horimoto M et al. Gastroenterological Endoscopy 41: 2051–7. | 65 | M | dysphagia | 1.9 | 0.5 | (–) | Mt | 0Ip | 8 | 2 | 2 | 0 | 0 | (–) | III | Sub | * | * | so-called | KL | VIM | (–) | 10 | Alive |
Hosodani Y et al. Nippon Rinsho Geka Gakkai Zasshi 59: 122–6. | 71 | M | dysphagia | * | 1.8 | (–) | Ut | 1 | 8 | 2 | 3 | 0 | 0 | (–) | III | Sub | (–) | (+)post | so-called | EMA, KL | EMA, VIM | (–) | 9 | Alive |
Iyama H et al. Endoscopic Forum for Digestive Disease 14: 12–7. | 77 | M | dysphagia | 3.9 | 6.1 | (–) | Lt | 0Ip | 5 | 2 | 2 | 0 | 1 | (–) | III | Sub | * | * | so-called | * | KL | * | * | * |
Ohmi R et al. Nippon Rinsho Geka Gakkai Zasshi 60: 97–101. | 59 | M | chest pain | 3.1 | 6.5 | (–) | Mt | 1 | 11 | 2 | 4 | 0 | 0 | (–) | IV a | Sub | (–) | (–) | authentic | KL, EMA | SMA | (–) | 26 | Alive |
Kubota S et al. Surg Today 29: 777–81. | 60 | M | dysphagia | * | * | (–) | Mt | 3 | 10 | 4 | 2 | 0 | 0 | (–) | IV a | Sub | (+)post | (–) | pseudo | KL | VIM | (–) | 10 | Alive |
Sonoda N et al. Gastroenterological endoscopy 41: 42–8. | 63 | M | dysphagia | 1.8 | 0.8 | (–) | Ae | 2 | 4.5 | 3 | 3 | 0 | 0 | (–) | IV a | Par | * | * | authentic | KL | VIM | * | * | * |
Kohara Y et al. Gann no Rinsho 40: 977–82. | 65 | M | dysphagia | 5.7 | 1.2 | (–) | Ut | 0Ip | 3.5 | 1b | 4 | 0 | 0 | (–) | IV a | Total | (+)post | (+)post | so-called | KL | VIM | Skin, Local | 12 | Dead |
Kishimoto H et al. Geka 64: 713–6. | 67 | M | dysphagia | 0.9 | 2.8 | (–) | Lt | 3 | 10 | 3 | 4 | 0 | 1 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | VIM, EMA | LN | 4 | Dead |
Satou Y et al. Akitaken Noson Igakkai Zasshi 39: 11–6. | 66 | M | fever | * | * | (–) | Mt | 0Ip | 14 | 1b | 3 | 0 | 0 | (–) | IV a | Sub | (+)post | (+)post | so-called | * | * | lung | 27 | Dead |
N: lymph node metastasis; N0: no lymph node metastasis; N1: metastasis to group 1 lymph node; N2: metastasis to group 2 lymph node; N3: metastasis to group 3 lymph node; N4: metastasis to group 4 lymph node; M: distant organ metastasis; M0: absence; M1: presence; IM: intramural metastasis; IDG: Superficial extension; Stage: histologic stage; Op: operation; Sub: subtotal esophagectomy; Tot: total esophagectomy; Par: partial esophagectomy; evulsion: esophagectomy without thoracotomy; chemo: chemotherapy; pre: preoperative; post: postoperative; RT: radiation; Type (H): histologic classification; Immuno-st: immunohistochemical study; c. carcinoma components; sa: sarcoma components; KL: keratin; Rec: recurrence; H: liver; LM: lung; Outcome: month/dead or alive;
not mentioned.
In our case, liver metastases and peritoneal dissemination were accompanied by metachronous IM consisting mainly of sarcomatous components. IM is defined as metastasis from an esophageal carcinoma to the esophageal or gastric wall not accompanied by extension of intraepithelial cancer. Recent studies have shown IM in approximately 10% of esophageal SCC.6,7 This spread pattern is considered important in cases of esophageal SCC because the presence of IM indicates a poor prognosis. The prognosis for esophageal carcinoma with IM is much poorer than that for carcinoma without IM. Patients with IM usually have lymph node metastasis and lymphatic invasion.8–10 The frequencies are reported to be 79% to 99% and 76% to 100%, respectively.6 IM has been interpreted to represent tumor extension via submucosal lymphatics resulting in lymph node metastasis or lymphatic embolus.11
IM is considered the typical spread pattern of esophageal SCC. According to Japanese case reports, sarcoma-predominant components were mainly observed in distant metastatic lesions, in peritoneal dissemination, and rarely in lymph node metastases (Tables 1, 2). IM was found in three (5.3%) of the total 58 cases of esophageal carcinosarcoma, a frequency that is much lower than that in cases of SCC. According to our review (Table 1a,b), in two of three cases accompanied by IM, lymph node metastasis was not found. Thus, we believe that the spread of IM in case of carcinosarcoma is not explained by lymphatic growth but rather by other pathways such as the bloodstream.
In our case, IM occurred as a papillary lesion limited to the submucosa, and the nearby epithelium was lined with normal cells. There are two possible explanations for the progression of the tumor in this case: (i) sarcomatous components of the primary lesion formed a metastatic lesion in the esophageal wall; or (ii) SCC components of the primary tumor formed an IM and differentiated secondarily to sarcomatous cells. In the primary tumor in our case, the distribution of SCC components was equal to that of sarcomatous components. Whereas in the metastatic lesions including the IM, sarcomatous components predominated SCC components. This change in histologic distribution from the primary to the metastatic sites suggests that sarcomatous components in carcinosarcoma arise from SCC. However, the sarcomatous cells did not stain positively for keratin, so our hypothesis is not confirmed.
By analysis for chromosomal loss of heterozygosity, Iwata et al. found that SCC and sarcoma originated separately from epithelial and mesenchymal precursors.12 Ota et al. reported that the presence of G-CSF in both SCC cells and sarcoma cells indicated that these components originated from a single clone.13 The findings of Ota et al. are supported by our review of Japanese case reports; in five (9%) of 57 cases, G-CSF production was observed.
To prove our hypothesis that sarcomatous components arise out of morphologic change from SCC, a comprehensive analysis to identify common markers of these two components is needed.